JAK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A1L429 | Y10 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A5YKK6 | Y851 | Sugiyama | CNOT1 CDC39 KIAA1007 NOT1 AD-005 | QVWPEANQHFSKEIDDEANSyFQRIYNHPPHPTMSVDEVLE |
| A6NDE8 | Y10 | Sugiyama | GAGE12H | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A6NER3 | Y10 | Sugiyama | GAGE12J | ___________MSWRGRsTyyWPRPRPYVQPPEMIGPMRPE |
| A6NHL2 | Y319 | Sugiyama | TUBAL3 | TTACFESSNQLVKCDPRLGKyMACCLLyRGDVVPKEVNAAI |
| O00115 | Y53 | Sugiyama | DNASE2 DNASE2A DNL2 | YKLPALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEG |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00232 | S21 | Sugiyama | PSMD12 | MADGGSERADGRIVKMEVDysATVDQRLPECAKLAKEGRLQ |
| O00232 | Y20 | Sugiyama | PSMD12 | _MADGGSERADGRIVKMEVDysATVDQRLPECAKLAKEGRL |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00429 | Y266 | Sugiyama | DNM1L DLP1 DRP1 | NRSQLDINNKKSVTDsIRDEyAFLQKKYPSLANRNGTKYLA |
| O00469 | S600 | Sugiyama | PLOD2 | VEEMEHyGKWSGGKHHDsRIsGGyENVPTDDIHMKQVDLEN |
| O00469 | Y199 | Sugiyama | PLOD2 | IVQQWNLQDNDDDQLFyTKVyIDPLKREAINITLDHKCKIF |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00469 | Y603 | Sugiyama | PLOD2 | MEHyGKWSGGKHHDsRIsGGyENVPTDDIHMKQVDLENVWL |
| O00571 | Y38 | Sugiyama | DDX3X DBX DDX3 | GLDLNssDNQsGGstAsKGRyIPPHLRNREATKGFyDKDSS |
| O00625 | Y131 | Sugiyama | PIR | AHGLQLWVNLRSSEKMVEPQyQELKSEEIPKPSKDGVTVAV |
| O14543 | Y204 | EPSD|PSP | SOCS3 CIS3 SSI3 | SNVATLQHLCRKTVNGHLDSyEKVTQLPGPIREFLDQyDAP |
| O14543 | Y221 | EPSD|PSP | SOCS3 CIS3 SSI3 | LDSyEKVTQLPGPIREFLDQyDAPL________________ |
| O14602 | Y35 | Sugiyama | EIF1AY | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEALCFDGV |
| O14639 | Y439 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | ERQsLGEsPRtLsPtPsAEGyQDVRDRMIHRstsQGsINsP |
| O14744 | Y297 | SIGNOR|EPSD|PSP | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | FCSYLQYLEYLSQNRPPPNAyELFAKGyEDyLQsPLQPLMD |
| O14744 | Y304 | EPSD|PSP | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | LEYLSQNRPPPNAyELFAKGyEDyLQsPLQPLMDNLESQTy |
| O14744 | Y307 | EPSD|PSP | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | LSQNRPPPNAyELFAKGyEDyLQsPLQPLMDNLESQTyEVF |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14828 | Y35 | Sugiyama | SCAMP3 C1orf3 PROPIN1 | sELDNPFQDPAVIQHRPsRQyATLDVyNPFETREPPPAyEP |
| O14828 | Y41 | Sugiyama | SCAMP3 C1orf3 PROPIN1 | FQDPAVIQHRPsRQyATLDVyNPFETREPPPAyEPPAPAPL |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14964 | Y216 | Sugiyama | HGS HRS | KYSTIPKFGIEKEVRVCEPCyEQLNRKAEGKAtsttELPPE |
| O14974 | Y669 | Sugiyama | PPP1R12A MBS MYPT1 | TTTTAGTVSSTTEVRERRRsyLtPVRDEEsEsQRKARSRQA |
| O14974 | Y901 | Sugiyama | PPP1R12A MBS MYPT1 | EtQtDsIsRyETssTsAGDRyDsLLGRsGsysYLEERKPYS |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15212 | Y82 | Sugiyama | PFDN6 HKE2 PFD6 | PVLVKQELGEARAtVGKRLDyItAEIKRYESQLRDLERQsE |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15230 | Y823 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | VCGQACASCKDGFFGLDQADyFGCRSCRCDIGGALGQSCEP |
| O15294 | Y316 | Sugiyama | OGT | YCNLANALKEKGSVAEAEDCyNTALRLCPTHADSLNNLANI |
| O15357 | Y1135 | Sugiyama | INPPL1 SHIP2 | SGDDRSCSVLQMAKTLSEVDyAPAGPARSALLPGPLELQPP |
| O15371 | Y30 | Sugiyama | EIF3D EIF3S7 | QDNPSGWGPCAVPEQFRDMPyQPFsKGDRLGKVADWtGAty |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15460 | Y79 | Sugiyama | P4HA2 UNQ290/PRO330 | KSWANKMEALTSKSAADAEGyLAHPVNAyKLVKRLNTDWPA |
| O15460 | Y87 | Sugiyama | P4HA2 UNQ290/PRO330 | ALTSKSAADAEGyLAHPVNAyKLVKRLNTDWPALEDLVLQD |
| O15523 | Y38 | Sugiyama | DDX3Y DBY | NLDLNSEKQSGGASTASKGRyIPPHLRNREASKGFHDKDSS |
| O43379 | Y975 | Sugiyama | WDR62 C19orf14 | DSQYCRKEVEAGPGDQQGDsyLRVssDsPKDQsPPEDsGEs |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43399 | Y106 | Sugiyama | TPD52L2 | LGELKQNLsRsWHDVQVssAyVKTSEKLGEWNEKVTQSDLy |
| O43615 | Y201 | Sugiyama | TIMM44 MIMT44 TIM44 | QGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKFKEE |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y611 | Sugiyama | ACTN4 | HKEAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVP |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43707 | Y898 | Sugiyama | ACTN4 | yCIARMAPyQGPDAVPGALDyKsFStALyGEsDL_______ |
| O43805 | Y82 | Sugiyama | SSNA1 NA14 | ARKIASRNEFDRTIAETEAAyLKILESSQTLLSVLKREAGN |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y129 | Sugiyama | CALU | VERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDDGFNY |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y213 | Sugiyama | CALU | VQEtMEDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTE |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y294 | Sugiyama | CALU | VyEsDQNKDGKLTKEEIVDKyDLFVGsQAtDFGEALVRHDE |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60488 | Y582 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | DGCLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNIC |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60664 | S93 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQP |
| O60664 | Y235 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AtsLDGFDVAsVQQQRQEQSyFVRLGsLSERLRQHAyEHsL |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60674 | S1016 | Sugiyama | JAK2 | GLTKVLPQDKEyyKVKEPGEsPIFWyAPESLTESKFSVASD |
| O60674 | S523 | SIGNOR|EPSD|PSP | JAK2 | PKDKSNLLVFRTNGVsDVPtsPTLQRPTHMNQMVFHKIRNE |
| O60674 | Y1007 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | JAK2 | ENRVKIGDFGLTKVLPQDKEyyKVKEPGEsPIFWyAPESLT |
| O60674 | Y1008 | GPS6|ELM|iPTMNet|EPSD | JAK2 | NRVKIGDFGLTKVLPQDKEyyKVKEPGEsPIFWyAPESLTE |
| O60674 | Y1021 | Sugiyama | JAK2 | LPQDKEyyKVKEPGEsPIFWyAPESLTESKFSVASDVWSFG |
| O60674 | Y119 | EPSD|PSP | JAK2 | NHVFHIDESTRHNVLYRIRFyFPRWYCSGSNRAYRHGISRG |
| O60674 | Y201 | SIGNOR|iPTMNet|EPSD | JAK2 | MAVLDMMRIAKENDQTPLAIyNSISyKTFLPKCIRAKIQDy |
| O60674 | Y206 | iPTMNet|EPSD | JAK2 | MMRIAKENDQTPLAIyNSISyKTFLPKCIRAKIQDyHILTR |
| O60674 | Y221 | GPS6|SIGNOR|iPTMNet|EPSD | JAK2 | yNSISyKTFLPKCIRAKIQDyHILTRKRIRYRFRRFIQQFS |
| O60674 | Y317 | SIGNOR | JAK2 | QWSRGKHKESETLTEQDLQLyCDFPNIIDVSIKQANQEGSN |
| O60674 | Y570 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | JAK2 | SLGQGTFTKIFKGVRREVGDyGQLHETEVLLKVLDKAHRNY |
| O60674 | Y637 | SIGNOR | JAK2 | VCGDENILVQEFVKFGSLDTyLKKNKNCINILWKLEVAKQL |
| O60674 | Y813 | SIGNOR|iPTMNet|EPSD | JAK2 | DFRPSFRAIIRDLNSLFTPDyELLTENDMLPNMRIGALGFS |
| O60674 | Y868 | SIGNOR | JAK2 | HLKFLQQLGKGNFGSVEMCRyDPLQDNTGEVVAVKKLQHST |
| O60674 | Y966 | SIGNOR | JAK2 | ERIDHIKLLQYTSQICKGMEyLGTKRyIHRDLATRNILVEN |
| O60674 | Y972 | SIGNOR | JAK2 | KLLQYTSQICKGMEyLGTKRyIHRDLATRNILVENENRVKI |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60739 | Y54 | Sugiyama | EIF1B | RIQQRNGRKtLttVQGIADDyDKKKLVKAFKKKFACNGtVI |
| O60763 | Y655 | Sugiyama | USO1 VDP | DKKEEEVKKTLEQHDNIVTHyKNMIREQDLQLEELRQQVST |
| O60828 | S210 | Sugiyama | PQBP1 NPW38 JM26 | SKKAVSRKDEELDPMDPSsysDAPRGTWstGLPKRNEAKTG |
| O60885 | Y97 | SIGNOR|PSP | BRD4 HUNK1 | HQFAWPFQQPVDAVKLNLPDyyKIIKTPMDMGTIKKRLENN |
| O60885 | Y98 | SIGNOR|PSP | BRD4 HUNK1 | QFAWPFQQPVDAVKLNLPDyyKIIKTPMDMGTIKKRLENNY |
| O60934 | Y746 | Sugiyama | NBN NBS NBS1 P95 | EMEVQNQHAKEEsLADDLFRyNPyLKRRR____________ |
| O60934 | Y749 | Sugiyama | NBN NBS NBS1 P95 | VQNQHAKEEsLADDLFRyNPyLKRRR_______________ |
| O75083 | Y98 | Sugiyama | WDR1 | VSGKLRIWDTTQKEHLLKyEyQPFAGKIKDIAWTEDSKRIA |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75179 | Y2290 | Sugiyama | ANKRD17 GTAR KIAA0697 | GGSVVSSQSTPESMLSGKSSyLPNsDPLHQSDTSKAPGFRP |
| O75223 | Y156 | Sugiyama | GGCT C7orf24 CRF21 | sPQYKKIICMGAKENGLPLEyQEKLKAIEPNDytGKVsEEI |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75369 | Y2276 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | EPGNYEVSIKFNDEHIPEsPyLVPVIAPSDDARRLTVMSLQ |
| O75369 | Y2502 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ANEtssILVEsVTRsstETCysAIPKASSDASKVTSKGAGL |
| O75369 | Y904 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | FNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTY |
| O75380 | Y100 | Sugiyama | NDUFS6 | VETRVIACDGGGGALGHPKVyINLDKETKTGTCGYCGLQFR |
| O75475 | Y18 | Sugiyama | PSIP1 DFS70 LEDGF PSIP2 | ___MTRDFKPGDLIFAKMKGyPHWPARVDEVPDGAVKPPTN |
| O75533 | Y152 | Sugiyama | SF3B1 SAP155 | RLDPFADGGKtPDPKMNARTyMDVMREQHLTKEEREIRQQL |
| O75688 | Y367 | Sugiyama | PPM1B PP2CB | IPNLPPGGGLAGKRNVIEAVySRLNPHREsDGAsDEAEEsG |
| O75718 | Y390 | Sugiyama | CRTAP CASP | ELyDFAKENIMDDDEGEVVEyVDDLLELEETS_________ |
| O75794 | Y301 | Sugiyama | CDC123 C10orf7 D123 | EQDSPAFRCTNSEVtVQPsPyLsyRLPKDFVDLsTGEDAHK |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O76070 | Y39 | Sugiyama | SNCG BCSG1 PERSYN PRSN | VEKTKQGVTEAAEKTKEGVMyVGAKtKENVVQsVTsVAEKT |
| O76087 | Y10 | Sugiyama | GAGE7 GAGE12I GAGE7B | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| O94842 | Y591 | Sugiyama | TOX4 C14orf92 KIAA0737 | RCVRsGCENPPIVSKDWDNEyCSNECVVKHCRDVFLAWVAS |
| O95197 | Y1004 | Sugiyama | RTN3 ASYIP NSPL2 | ELLIFSVPIVYEKYKTQIDHyVGIARDQTKSIVEKIQAKLP |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95376 | Y289 | Sugiyama | ARIH2 ARI2 TRIAD1 HT005 | DCATIRKWLTKCADDSETANyISAHTKDCPKCNICIEKNGG |
| O95573 | Y591 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | DGCLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNIC |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95861 | Y293 | Sugiyama | BPNT1 | HKDVKHMNSAGVLAtLRNyDyyASRVPESIKNALVP_____ |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| O95926 | Y210 | Sugiyama | SYF2 CBPIN GCIPIP | IEKRDKYSRRRPYNDDADIDyINERNAKFNKKAERFYGKYT |
| O96017 | Y156 | PSP | CHEK2 CDS1 CHK2 RAD53 | YRTYsKKHFRIFREVGPKNSyIAYIEDHsGNGTFVNTELVG |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y172 | Sugiyama | LDHA PIG19 | GFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHGWVLGE |
| P00491 | Y166 | Sugiyama | PNP NP | PLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGEQRE |
| P00505 | Y179 | Sugiyama | GOT2 KYAT4 | KPTWGNHtPIFRDAGMQLQGyRYYDPKtCGFDFtGAVEDIS |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00533 | Y1069 | SIGNOR|iPTMNet|EPSD | EGFR ERBB ERBB1 HER1 | CIDRNGLQsCPIKEDsFLQRyssDPtGALtEDsIDDtFLPV |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00568 | Y34 | Sugiyama | AK1 | VGGPGSGKGTQCEKIVQKyGytHLstGDLLRSEVSSGSARG |
| P00813 | Y240 | Sugiyama | ADA ADA1 | SAEVVKEAVDILKTERLGHGyHtLEDQALyNRLRQENMHFE |
| P00813 | Y249 | Sugiyama | ADA ADA1 | DILKTERLGHGyHtLEDQALyNRLRQENMHFEICPWSSYLT |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P01023 | T1010 | Sugiyama | A2M CPAMD5 FWP007 | LNETQQLTPEIKSKAIGyLNtGYQRQLNYKHYDGSYSTFGE |
| P01023 | Y1007 | Sugiyama | A2M CPAMD5 FWP007 | LDYLNETQQLTPEIKSKAIGyLNtGYQRQLNYKHYDGSYST |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P02786 | Y168 | Sugiyama | TFRC | NENsyVPREAGsQKDENLALyVENQFREFKLSKVWRDQHFV |
| P02786 | Y20 | Sugiyama | TFRC | _MMDQARsAFsNLFGGEPLsytRFsLARQVDGDNsHVEMKL |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P02786 | Y683 | Sugiyama | TFRC | AEKTDRFVMKKLNDRVMRVEyHFLSPyVSPKESPFRHVFWG |
| P02786 | Y689 | Sugiyama | TFRC | FVMKKLNDRVMRVEyHFLSPyVSPKESPFRHVFWGSGSHTL |
| P04040 | Y447 | Sugiyama | CAT | GEVRRFNtANDDNVtQVRAFyVNVLNEEQRKRLCENIAGHL |
| P04049 | Y340 | SIGNOR|iPTMNet|EPSD | RAF1 RAF | PVsGtQEKNKIRPRGQRDssyyWEIEASEVMLSTRIGsGsF |
| P04049 | Y341 | SIGNOR|iPTMNet|EPSD | RAF1 RAF | VsGtQEKNKIRPRGQRDssyyWEIEASEVMLSTRIGsGsFG |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04181 | Y50 | Sugiyama | OAT | TKKtVQGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyL |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | Y23 | Sugiyama | HSPB1 HSP27 HSP28 | ERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGLPRLPEEWS |
| P04899 | Y168 | Sugiyama | GNAI2 GNAI2B | QLNDSAAYYLNDLERIAQSDyIPTQQDVLRTRVKTTGIVET |
| P05023 | Y542 | Sugiyama | ATP1A1 | LLHGKEQPLDEELKDAFQNAyLELGGLGERVLGFCHLFLPD |
| P05362 | T454 | Sugiyama | ICAM1 | DGtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNV |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05387 | Y3 | Sugiyama | RPLP2 D11S2243E RPP2 | __________________MRyVAsyLLAALGGNssPsAKDI |
| P05387 | Y7 | Sugiyama | RPLP2 D11S2243E RPP2 | ______________MRyVAsyLLAALGGNssPsAKDIKKIL |
| P06730 | Y34 | Sugiyama | EIF4E EIF4EL1 EIF4F | PPttEEEKtEsNQEVANPEHyIKHPLQNRWALWFFKNDKsK |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | Y131 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ILGVsLAVCKAGAVEKGVPLyRHIADLAGNsEVILPVPAFN |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07108 | Y29 | Sugiyama | DBI | AAEEVRHLKTKPsDEEMLFIyGHyKQAtVGDINtERPGMLD |
| P07108 | Y32 | Sugiyama | DBI | EVRHLKTKPsDEEMLFIyGHyKQAtVGDINtERPGMLDFTG |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07437 | S338 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | RGRMsMKEVDEQMLNVQNKNssyFVEWIPNNVKTAVCDIPP |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07602 | Y113 | Sugiyama | PSAP GLBA SAP1 | TCDWLPKPNMSASCKEIVDSyLPVILDIIKGEMSRPGEVCS |
| P07686 | Y547 | Sugiyama | HEXB HCC7 | DRLTRHRCRMVERGIAAQPLyAGyCNHENM___________ |
| P07711 | Y330 | Sugiyama | CTSL CTSL1 | GyVKMAKDRRNHCGIAsAAsyPtV_________________ |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07814 | Y507 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | MEWDKIWAFNKKVIDPVAPRyVALLKKEVIPVNVPEAQEEM |
| P07814 | Y872 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EAVECLLSLKAQYKEKTGKEyIPGQPPLsQssDssPtRNsE |
| P07858 | Y215 | Sugiyama | CTSB CPSB | RPPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNS |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07900 | Y627 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIEtLR |
| P08195 | S402 | Sugiyama | SLC3A2 MDU1 | SSDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQY |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y520 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VERVRKRGFEVVyMtEPIDEyCVQQLKEFDGKsLVsVtKEG |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08559 | Y301 | PSP | PDHA1 PHE1A | LMELQTYRyHGHsMsDPGVsyRtREEIQEVRsKsDPIMLLK |
| P08865 | Y156 | Sugiyama | RPSA LAMBR LAMR1 | EAsyVNLPtIALCNTDSPLRyVDIAIPCNNKGAHSVGLMWW |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09382 | Y120 | Sugiyama | LGALS1 | KLPDGyEFKFPNRLNLEAINyMAADGDFKIKCVAFD_____ |
| P09651 | Y244 | Sugiyama | HNRNPA1 HNRPA1 | GRGGFGGSRGGGGYGGSGDGyNGFGNDGGyGGGGPGYSGGS |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09874 | Y794 | Sugiyama | PARP1 ADPRT PPOL | AySLLRGGsDDssKDPIDVNyEKLKTDIKVVDRDSEEAEII |
| P09972 | Y358 | Sugiyama | ALDOC ALDC | AAQGKYEGSGEDGGAAAQsLyIANHAY______________ |
| P0CL80 | Y10 | Sugiyama | GAGE12F | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P0DPB6 | Y70 | Sugiyama | POLR1D | TLGNSLRYMIMKNPEVEFCGyTTTHPSEsKINLRIQTRGTL |
| P0DPH7 | T225 | Sugiyama | TUBA3C TUBA2 | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| P0DSO3 | Y10 | Sugiyama | GAGE4 | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P10912 | Y332 | GPS6|ELM|iPTMNet|EPSD | GHR | DLLKEGKLEEVNTILAIHDSyKPEFHSDDSWVEFIELDIDE |
| P10912 | Y487 | GPS6|ELM|iPTMNet|EPSD | GHR | THQAAHIQLSNPSSLSNIDFyAQVSDITPAGSVVLSPGQKN |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11047 | Y811 | Sugiyama | LAMC1 LAMB2 | VCTNCPTGTTGKRCELCDDGyFGDPLGRNGPVRLCRLCQCS |
| P11142 | S432 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGERAMTKD |
| P11142 | Y149 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIAEAyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNV |
| P11142 | Y371 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | QDFFNGKELNKsINPDEAVAyGAAVQAAILsGDKSENVQDL |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11233 | Y153 | Sugiyama | RALA RAL | DKRQVsVEEAKNRAEQWNVNyVETSAKTRANVDKVFFDLMR |
| P11274 | Y177 | GPS6 | BCR BCR1 D22S11 | NFERIRKGHGQPGADAEKPFyVNVEFHHERGLVKVNDKEVS |
| P11413 | Y118 | Sugiyama | G6PD | LEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGsQANRLF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12004 | Y249 | Sugiyama | PCNA | MSADVPLVVEYKIADMGHLKyyLAPKIEDEEGs________ |
| P12004 | Y250 | Sugiyama | PCNA | SADVPLVVEYKIADMGHLKyyLAPKIEDEEGs_________ |
| P12270 | Y140 | Sugiyama | TPR | LEAEKRDLIRTNERLsQELEyLTEDVKRLNEKLKESNTTKG |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13073 | Y38 | Sugiyama | COX4I1 COX4 | SVCVRAHESVVKsEDFsLPAyMDRRDHPLPEVAHVKHLSAS |
| P13639 | T582 | Sugiyama | EEF2 EF2 | EEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRL |
| P13639 | Y265 | Sugiyama | EEF2 EF2 | GPAERAKKVEDMMKKLWGDRyFDPANGKFSKSATsPEGKKL |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13667 | Y252 | Sugiyama | PDIA4 ERP70 ERP72 | LAKVDAtAETDLAKRFDVsGyPTLKIFRKGRPYDYNGPREK |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y604 | Sugiyama | PDIA4 ERP70 ERP72 | DATANDVPSDRyKVEGFPTIyFAPSGDKKNPVKFEGGDRDL |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13929 | Y131 | Sugiyama | ENO3 | ILGVSLAVCKAGAAEKGVPLyRHIADLAGNPDLILPVPAFN |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P13987 | Y87 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | FEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTSL |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14324 | Y349 | Sugiyama | FDPS FPS KIAA1293 | QDNKCSWLVVQCLQRATPEQyQILKENYGQKEAEKVARVKA |
| P14618 | Y105 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AEtIKNVRtAtEsFAsDPILyRPVAVALDTKGPEIRtGLIK |
| P14618 | Y83 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | EMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPI |
| P14625 | Y258 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GNTLGRGTTITLVLKEEAsDyLELDTIKNLVKKYSQFINFP |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y34 | Sugiyama | COX6B1 COX6B | TAPFDSRFPNQNQTRNCWQNyLDFHRCQKAMTAKGGDIsVC |
| P14866 | Y285 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | IEYAKPTRLNVFKNDQDtWDyTNPNLsGQGDPGsNPNKRQR |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15880 | T252 | Sugiyama | RPS2 RPS4 | tLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFtDH |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P15924 | Y56 | Sugiyama | DSP | GtsRMYYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQ |
| P16410 | Y201 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CTLA4 CD152 | LTAVSLSKMLKKRSPLTTGVyVKMPPTEPECEKQFQPyFIP |
| P16471 | S349 | PSP | PRLR | HSKEHPSQGMKPTYLDPDTDsGRGSCDSPSLLSEKCEEPQA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17676 | Y137 | Sugiyama | CEBPB TCF5 PP9092 | FLSDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCF |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P17931 | Y221 | Sugiyama | LGALS3 MAC2 | QVLVEPDHFKVAVNDAHLLQyNHRVKKLNEISKLGISGDID |
| P17980 | Y168 | Sugiyama | PSMC3 TBP1 | GDLVGVNKDSyLILEtLPtEyDsRVKAMEVDERPtEQysDI |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18084 | Y509 | Sugiyama | ITGB5 | CSPGYLGTRCECQDGENQsVyQNLCREAEGKPLCSGRGDCS |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y133 | Sugiyama | PGAM1 PGAMA CDABP0006 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsC |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19235 | Y368 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | EPOR | GTDDEGPLLEPVGSEHAQDTyLVLDKWLLPRNPPSEDLPGP |
| P19235 | Y426 | SIGNOR|iPTMNet|EPSD | EPOR | CSSALASKPSPEGASAASFEyTILDPSSQLLRPWTLCPELP |
| P19235 | Y454 | SIGNOR|iPTMNet|EPSD | EPOR | QLLRPWTLCPELPPTPPHLKyLyLVVSDSGISTDySSGDSQ |
| P19235 | Y456 | SIGNOR|iPTMNet|EPSD | EPOR | LRPWTLCPELPPTPPHLKyLyLVVSDSGISTDySSGDSQGA |
| P19235 | Y468 | SIGNOR|iPTMNet|EPSD | EPOR | TPPHLKyLyLVVSDSGISTDySSGDSQGAQGGLSDGPySNP |
| P19235 | Y485 | SIGNOR|iPTMNet|EPSD | EPOR | STDySSGDSQGAQGGLSDGPySNPyENSLIPAAEPLPPSyV |
| P19235 | Y489 | SIGNOR|iPTMNet|EPSD | EPOR | SSGDSQGAQGGLSDGPySNPyENSLIPAAEPLPPSyVACS_ |
| P19235 | Y504 | SIGNOR|iPTMNet|EPSD | EPOR | PySNPyENSLIPAAEPLPPSyVACS________________ |
| P19338 | Y351 | Sugiyama | NCL | FAKNDLAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKV |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20810 | Y339 | Sugiyama | CAST | KAKEEKLEKCGEDDEtIPsEyRLKPATDKDGKPLLPEPEEK |
| P20810 | Y618 | Sugiyama | CAST | KAKAEHRDKLGERDDTIPPEyRHLLDDNGQDKPVKPPTKKS |
| P21127 | Y425 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | DYVPDSPALSPIELKQELPKyLPALQGCRsVEEFQCLNRIE |
| P21333 | Y635 | Sugiyama | FLNA FLN FLN1 | GPSQAKIECDDKGDGsCDVRyWPQEAGEyAVHVLCNsEDIR |
| P21333 | Y643 | Sugiyama | FLNA FLN FLN1 | CDDKGDGsCDVRyWPQEAGEyAVHVLCNsEDIRLsPFMADI |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22059 | Y767 | Sugiyama | OSBP OSBP1 | RKKREAEAMKATEDGtPYDPyKALWFERKKDPVTKELTHIy |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | Y244 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GsNFRGGsDGyGsGRGFGDGyNGyGGGPGGGNFGGsPGyGG |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23434 | Y164 | Sugiyama | GCSH | LIKMtLsNPsELDELMsEEAyEKYIKSIEE___________ |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P23588 | Y593 | Sugiyama | EIF4B | APEPKKPEENPASKFssASKyAALsVDGEDENEGEDyAE__ |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P23921 | T555 | Sugiyama | RRM1 RR1 | IyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTP |
| P23921 | Y553 | Sugiyama | RRM1 RR1 | EtIyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNV |
| P23921 | Y74 | Sugiyama | RRM1 RR1 | VELDTLAAETAATLTTKHPDyAILAARIAVSNLHKETKKVF |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P24666 | Y88 | Sugiyama | ACP1 | GIPMSHVARQITKEDFAtFDyILCMDESNLRDLNRKSNQVK |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y219 | Sugiyama | ACAT1 ACAT MAT | NTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVt |
| P24752 | Y256 | Sugiyama | ACAT1 ACAT MAT | IPVtVtVKGQPDVVVKEDEEyKRVDFSKVPKLKTVFQKENG |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y45 | Sugiyama | MCM3 | DEEDQGIyQsKVRELIsDNQyRLIVNVNDLRRKNEKRANRL |
| P25205 | Y708 | Sugiyama | MCM3 | KRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADs |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y5 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | ________________MGKDyyQTLGLARGAsDEEIKRAYR |
| P25685 | Y6 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | _______________MGKDyyQTLGLARGAsDEEIKRAYRR |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26639 | T56 | Sugiyama | TARS1 TARS | KEGsGDGGRAELNPWPEyIytRLEMYNILKAEHDsILAEKA |
| P26639 | Y53 | Sugiyama | TARS1 TARS | KKNKEGsGDGGRAELNPWPEyIytRLEMYNILKAEHDsILA |
| P26640 | Y601 | Sugiyama | VARS1 G7A VARS VARS2 | VDMDFGTGAVKITPAHDQNDyEVGQRHGLEAIsIMDsRGAL |
| P26641 | Y416 | Sugiyama | EEF1G EF1G PRO1608 | SyTWRKLDPGsEEtQtLVREyFSWEGAFQHVGKAFNQGKIF |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27361 | Y204 | EPSD|PSP | MAPK3 ERK1 PRKM3 | DFGLARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGYTK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P28482 | Y187 | EPSD|PSP | MAPK1 ERK2 PRKM1 PRKM2 | DFGLARVADPDHDHtGFLtEyVAtRWyRAPEIMLNSKGYTK |
| P28799 | Y294 | Sugiyama | GRN | LPAHTVGDVKCDMEVSCPDGyTCCRLQSGAWGCCPFTQAVC |
| P29144 | Y1052 | Sugiyama | TPP2 | WMTKLDSsDIyNELKEtyPNyLPLyVARLHQLDAEKERMKR |
| P29144 | Y1056 | Sugiyama | TPP2 | LDSsDIyNELKEtyPNyLPLyVARLHQLDAEKERMKRLNEI |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y202 | Sugiyama | TKT | LDINRLGQsDPAPLQHQMDIyQKRCEAFGWHAIIVDGHSVE |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30040 | Y115 | Sugiyama | ERP29 C12orf8 ERP28 | DyGDKLNMELSEKYKLDKESyPVFyLFRDGDFENPVPyTGA |
| P30040 | Y119 | Sugiyama | ERP29 C12orf8 ERP28 | KLNMELSEKYKLDKESyPVFyLFRDGDFENPVPyTGAVKVG |
| P30040 | Y202 | Sugiyama | ERP29 C12orf8 ERP28 | KQGQDNLSSVKETQKKWAEQyLKIMGKILDQGEDFPAsEMT |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y125 | Sugiyama | PEBP1 PBP PEBP | DyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsNRsGDH |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y181 | Sugiyama | PEBP1 PBP PEBP | RAPVAGtCyQAEWDDyVPKLyEQLsGK______________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y454 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | MDAtANDVPsPyEVRGFPtIyFsPANKKLNPKKyEGGRELs |
| P30101 | Y479 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | NKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1031 | Sugiyama | CPS1 | VVVNCNPETVstDFDECDKLyFEELSLERILDIYHQEACGG |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31327 | Y1491 | Sugiyama | CPS1 | KLFAEAVQKSRKVDSKSLFHyRQysAGKAA___________ |
| P31327 | Y768 | Sugiyama | CPS1 | PEIKNVVSGKTsACFEPSLDyMVtKIPRWDLDRFHGTSSRI |
| P31939 | Y362 | Sugiyama | ATIC PURH OK/SW-cl.86 | IAPGyEEEALTILSKKKNGNyCVLQMDQsYKPDENEVRTLF |
| P31939 | Y558 | Sugiyama | ATIC PURH OK/SW-cl.86 | SDAFFPFRDNVDRAKRsGVAyIAAPSGsAADKVVIEACDEL |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | S212 | Sugiyama | YWHAB | SLAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtS |
| P31946 | Y106 | Sugiyama | YWHAB | EKIEAELQDICNDVLELLDKyLIPNATQPESKVFyLKMKGD |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y310 | Sugiyama | STIP1 | RENREDYRQIAKAYARIGNSyFKEEKYKDAIHFyNKSLAEH |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P33176 | Y62 | Sugiyama | KIF5B KNS KNS1 | ASKPYAFDRVFQSsTsQEQVyNDCAKKIVKDVLEGyNGtIF |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33992 | Y212 | Sugiyama | MCM5 CDC46 | ALPRKCNTDQAGRPKCPLDPyFIMPDKCKCVDFQtLKLQEL |
| P33993 | Y102 | Sugiyama | MCM7 CDC47 MCM2 | QELLPQYKEREVVNKDVLDVyIEHRLMMEQRSRDPGMVRsP |
| P33993 | Y333 | Sugiyama | MCM7 CDC47 MCM2 | EsGAGELtREELRQIAEEDFyEKLAASIAPEIYGHEDVKKA |
| P34896 | Y180 | Sugiyama | SHMT1 | ISATSIFFESMPYKVNPDtGyINyDQLEENARLFHPKLIIA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P35580 | Y13 | Sugiyama | MYH10 | ________MAQRTGLEDPERyLFVDRAVIYNPATQADWTAK |
| P35606 | Y193 | Sugiyama | COPB2 | GsssPNFTLEGHEKGVNCIDyysGGDKPyLIsGADDRLVKI |
| P35606 | Y194 | Sugiyama | COPB2 | sssPNFTLEGHEKGVNCIDyysGGDKPyLIsGADDRLVKIW |
| P35606 | Y824 | Sugiyama | COPB2 | AFVVEEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQP |
| P35813 | Y362 | Sugiyama | PPM1A PPPM1A | IPSLPPGGELASKRNVIEAVyNRLNPYKNDDTDsTsTDDMW |
| P36871 | Y157 | Sugiyama | PGM1 | GPAPEAITDKIFQISKTIEEyAVCPDLKVDLGVLGKQQFDL |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P36954 | Y54 | Sugiyama | POLR2I | ILLyACRNCDYQQEADNSCIyVNKITHEVDELtQIIADVsQ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P37837 | Y206 | Sugiyama | TALDO1 TAL TALDO TALDOR | ISPFVGRILDWHVANTDKKSyEPLEDPGVKSVTKIYNYYKK |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | T143 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | CEVtNLNDyRENVFKLLPQLtyLDGyDRDDKEAPDsDAEGY |
| P39687 | Y131 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | KLENLKsLDLFNCEVtNLNDyRENVFKLLPQLtyLDGyDRD |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40763 | Y176 | Sugiyama | STAT3 APRF | QDLEQKMKVVENLQDDFDFNyKTLKsQGDMQDLNGNNQsVT |
| P40763 | Y686 | Sugiyama | STAT3 APRF | LVSPLVYLYPDIPKEEAFGKyCRPEsQEHPEADPGsAAPyL |
| P40763 | Y705 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | STAT3 APRF | KyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNtIDLP |
| P41091 | Y102 | Sugiyama | EIF2S3 EIF2G | GYANAKIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKG |
| P41227 | Y145 | Sugiyama | NAA10 ARD1 ARD1A TE2 | TLNFQISEVEPKyyADGEDAyAMKRDLtQMADELRRHLELK |
| P41236 | Y148 | Sugiyama | PPP1R2 IPP2 | DLsPEEREKKRQFEMKRKLHyNEGLNIKLARQLISKDLHDD |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P41567 | Y54 | Sugiyama | EIF1 SUI1 | RIQQRNGRKtLttVQGIADDyDKKKLVKAFKKKFACNGtVI |
| P41597 | Y139 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CCR2 CMKBR2 | LYHIGYFGGIFFIILLTIDRyLAIVHAVFALKARTVTFGVV |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42166 | Y37 | Sugiyama | TMPO LAP2 | KSELVANNVTLPAGEQRKDVyVQLyLQHLTARNRPPLPAGT |
| P42166 | Y41 | Sugiyama | TMPO LAP2 | VANNVTLPAGEQRKDVyVQLyLQHLTARNRPPLPAGTNsKG |
| P42167 | Y37 | Sugiyama | TMPO LAP2 | KSELVANNVTLPAGEQRKDVyVQLyLQHLTARNRPPLPAGT |
| P42167 | Y41 | Sugiyama | TMPO LAP2 | VANNVTLPAGEQRKDVyVQLyLQHLTARNRPPLPAGTNSKG |
| P42224 | Y666 | Sugiyama | STAT1 | DIIRNYKVMAAENIPENPLKyLyPNIDKDHAFGKYYSRPKE |
| P42224 | Y668 | Sugiyama | STAT1 | IRNYKVMAAENIPENPLKyLyPNIDKDHAFGKYYSRPKEAP |
| P42224 | Y701 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | STAT1 | YSRPKEAPEPMELDGPKGtGyIKtELIsVsEVHPSRLQttD |
| P42226 | Y641 | ELM | STAT6 | KDEAFRSHYKPEQMGKDGRGyVPATIKMTVERDQPLPTPEL |
| P42229 | Y694 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | STAT5A STAT5 | PKDEVFSKYYTPVLAKAVDGyVKPQIKQVVPEFVNASADAG |
| P42680 | Y519 | GPS6 | TEC PSCTK4 | EAGVVKVSDFGMARyVLDDQytsSsGAKFPVKWCPPEVFNY |
| P42765 | Y198 | Sugiyama | ACAA2 | ECDKyALQSQQRWKAANDAGyFNDEMAPIEVKTKKGKQTMQ |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y243 | Sugiyama | MATR3 KIAA0723 | RLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGPLQER |
| P43246 | Y118 | Sugiyama | MSH2 | YRVEVYKNRAGNKASKENDWyLAYKASPGNLSQFEDILFGN |
| P45974 | Y70 | Sugiyama | USP5 ISOT | FLGFGKQYVERHFNKTGQRVyLHLRRTRRPKEEDPATGTGD |
| P46109 | Y15 | Sugiyama | CRKL | ______MSSARFDssDRsAWyMGPVsRQEAQtRLQGQRHGM |
| P46527 | Y88 | GPS6|EPSD | CDKN1B KIP1 p27 | KPLEGKyEWQEVEKGsLPEFyyRPPRPPKGACKVPAQEsQD |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46937 | Y407 | Sugiyama | YAP1 YAP65 | NsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGD |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47813 | Y35 | Sugiyama | EIF1AX EIF1A EIF4C | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEAMCFDGV |
| P47897 | S750 | Sugiyama | QARS1 QARS | CSVALAKPFDKFQFERLGyFsVDPDsHQGKLVFNRTVTLKE |
| P47897 | Y748 | Sugiyama | QARS1 QARS | VDCSVALAKPFDKFQFERLGyFsVDPDsHQGKLVFNRTVTL |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48147 | Y28 | Sugiyama | PREP PEP | DVYRDETAVQDYHGHKICDPyAWLEDPDSEQTKAFVEAQNK |
| P48357 | Y1141 | SIGNOR | LEPR DB OBR | SHFVENNINLGTSSKKTFASyMPQFQTCSTQTHKIMENKMC |
| P48357 | Y986 | SIGNOR | LEPR DB OBR | EAEGTEVTYEDESQRQPFVKyATLISNSKPSETGEEQGLIN |
| P48637 | S394 | Sugiyama | GSS | LyGEEMVQALKQLKDSEERAsyILMEKIEPEPFENCLLRPG |
| P48637 | Y395 | Sugiyama | GSS | yGEEMVQALKQLKDSEERAsyILMEKIEPEPFENCLLRPGs |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49419 | Y69 | Sugiyama | ALDH7A1 ATQ1 | EENEGVyNGSWGGRGEVIttyCPANNEPIARVRQAsVADyE |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P49588 | Y295 | Sugiyama | AARS1 AARS | GARPYTGKVGAEDADGIDMAyRVLADHARTITVALADGGRP |
| P49753 | Y351 | Sugiyama | ACOT2 PTE2 PTE2A | GETLPPVGVNRNRIKVTKDGyADIVDVLNsPLEGPDQKSFI |
| P50395 | Y203 | Sugiyama | GDI2 RABGDIB | DFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsP |
| P50502 | Y185 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | NAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51812 | S708 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | YQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQ |
| P51812 | Y707 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | QYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLA |
| P51858 | Y23 | Sugiyama | HDGF HMG1L2 | RSNRQKEYKCGDLVFAKMKGyPHWPARIDEMPEAAVKstAN |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52630 | Y690 | ELM | STAT2 | RDEAFGCYYQEKVNLQERRKyLKHRLIVVSNRQVDELQQPL |
| P52655 | Y365 | Sugiyama | GTF2A1 TF2A1 | SKNKWKFHLKDGIMNLNGRDyIFSKAIGDAEW_________ |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P52907 | T249 | Sugiyama | CAPZA1 | IKIIENAENEyQTAIsENyQtMSDTTFKALRRQLPVTRTKI |
| P52907 | Y239 | Sugiyama | CAPZA1 | sNEAQtAKEFIKIIENAENEyQTAIsENyQtMSDTTFKALR |
| P52907 | Y247 | Sugiyama | CAPZA1 | EFIKIIENAENEyQTAIsENyQtMSDTTFKALRRQLPVTRT |
| P52948 | Y741 | Sugiyama | NUP98 ADAR2 | EIENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECI |
| P52948 | Y742 | Sugiyama | NUP98 ADAR2 | IENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECIV |
| P53041 | Y422 | Sugiyama | PPP5C PPP5 | VsCQFGPDVTKAFLEENNLDyIIRSHEVKAEGYEVAHGGRC |
| P53611 | Y26 | Sugiyama | RABGGTB GGTB | KDVIIKsDAPDTLLLEKHADyIASYGSKKDDYEYCMSEYLR |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54577 | T290 | Sugiyama | YARS1 YARS | PLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLK |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55327 | Y136 | Sugiyama | TPD52 | LQELKQNIAKGWQDVTATSAyKKTSETLSQAGQKASAAFSS |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P55884 | Y232 | Sugiyama | EIF3B EIF3S9 | SKFGKITNDFyPEEDGKTKGyIFLEyAsPAHAVDAVKNADG |
| P55884 | Y237 | Sugiyama | EIF3B EIF3S9 | ITNDFyPEEDGKTKGyIFLEyAsPAHAVDAVKNADGYKLDK |
| P60174 | Y48 | Sugiyama | TPI1 TPI | tLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQNCy |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y159 | Sugiyama | PSMA6 PROS27 | ILIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFL |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61024 | Y8 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | _____________MSHKQIyysDKyDDEEFEyRHVMLPKDI |
| P61081 | T176 | Sugiyama | UBE2M UBC12 | NRRLFEQNVQRSMRGGyIGstyFERCLK_____________ |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61158 | Y16 | Sugiyama | ACTR3 ARP3 | _____MAGRLPACVVDCGtGytKLGYAGNTEPQFIIPSCIA |
| P61158 | Y231 | Sugiyama | ACTR3 ARP3 | REVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSK |
| P61158 | Y233 | Sugiyama | ACTR3 ARP3 | VGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKWI |
| P61163 | Y241 | Sugiyama | ACTR1A CTRN1 | ACYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPEL |
| P61163 | Y242 | Sugiyama | ACTR1A CTRN1 | CYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPELL |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61586 | Y156 | Sugiyama | RHOA ARH12 ARHA RHO12 | QEPVKPEEGRDMANRIGAFGyMECsAKTKDGVREVFEMAtR |
| P61604 | Y100 | Sugiyama | HSPE1 | KVVLDDKDyFLFRDGDILGKyVD__________________ |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62191 | Y439 | Sugiyama | PSMC1 | FKKSKENVLyKKQEGtPEGLyL___________________ |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S69 | Sugiyama | RPS14 PRO2640 | GKETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELG |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62306 | Y71 | Sugiyama | SNRPF PBSCF | IDGALSGHLGEVLIRCNNVLyIRGVEEEEEDGEMRE_____ |
| P62495 | Y345 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | NLDIMRYVLHCQGTEEEKILyLTPEQEKDKSHFTDKETGQE |
| P62633 | S121 | Sugiyama | CNBP RNF163 ZNF9 | CGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRCG |
| P62633 | Y120 | Sugiyama | CNBP RNF163 ZNF9 | NCGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRC |
| P62633 | Y75 | Sugiyama | CNBP RNF163 ZNF9 | YRCGESGHLAKDCDLQEDACyNCGRGGHIAKDCKEPKRERE |
| P62714 | Y80 | Sugiyama | PPP2CB | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62873 | Y145 | Sugiyama | GNB1 | NLKTREGNVRVSRELAGHTGyLsCCRFLDDNQIVTSSGDTT |
| P62879 | Y145 | Sugiyama | GNB2 | SLKTREGNVRVsRELPGHtGyLSCCRFLDDNQIITSSGDTT |
| P62899 | Y103 | Sugiyama | RPL31 | RIRVRLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVD |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P62993 | Y209 | EPSD|PSP | GRB2 ASH | SDPNWWKGACHGQTGMFPRNyVTPVNRNV____________ |
| P62993 | Y37 | EPSD|PSP | GRB2 ASH | LsFKRGDILKVLNEECDQNWyKAELNGKDGFIPKNyIEMKP |
| P62993 | Y52 | EPSD|PSP | GRB2 ASH | CDQNWyKAELNGKDGFIPKNyIEMKPHPWFFGKIPRAKAEE |
| P62993 | Y7 | EPSD|PSP | GRB2 ASH | ______________MEAIAKyDFKATADDELsFKRGDILKV |
| P63104 | S210 | Sugiyama | YWHAZ | SLAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWts |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63151 | S75 | Sugiyama | PPP2R2A | FQQEQENKIQSHSRGEyNVystFQsHEPEFDyLKSLEIEEK |
| P63151 | Y71 | Sugiyama | PPP2R2A | RVVIFQQEQENKIQSHSRGEyNVystFQsHEPEFDyLKSLE |
| P63151 | Y74 | Sugiyama | PPP2R2A | IFQQEQENKIQSHSRGEyNVystFQsHEPEFDyLKSLEIEE |
| P63151 | Y86 | Sugiyama | PPP2R2A | HSRGEyNVystFQsHEPEFDyLKSLEIEEKINKIRWLPQKN |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63241 | Y98 | Sugiyama | EIF5A | NMDVPNIKRNDFQLIGIQDGyLsLLQDSGEVREDLRLPEGD |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | Y80 | Sugiyama | PPP2CA | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | T225 | Sugiyama | TUBA1B | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| P68363 | Y312 | Sugiyama | TUBA1B | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68366 | T225 | Sugiyama | TUBA4A TUBA1 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| P68366 | Y312 | Sugiyama | TUBA4A TUBA1 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P68400 | Y323 | Sugiyama | CSNK2A1 CK2A1 | KLLRYDHQSRLTAREAMEHPyFytVVKDQARMGSSSMPGGS |
| P68400 | Y325 | Sugiyama | CSNK2A1 CK2A1 | LRYDHQSRLTAREAMEHPyFytVVKDQARMGSSSMPGGStP |
| P68431 | Y42 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ATKAARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELL |
| P78324 | Y496 | iPTMNet|EPSD | SIRPA BIT MFR MYD1 PTPNS1 SHPS1 SIRP | VHLNRTPKQPAPKPEPSFSEyASVQVPRK____________ |
| P78347 | Y248 | SIGNOR|iPTMNet|EPSD | GTF2I BAP135 WBSCR6 | SGIsLEMAAVTVKEESEDPDyyQYNIQAGPSETDDVDEKQP |
| P84022 | Y125 | Sugiyama | SMAD3 MADH3 | AMELCEFAFNMKKDEVCVNPyHyQRVEtPVLPPVLVPRHTE |
| P84022 | Y127 | Sugiyama | SMAD3 MADH3 | ELCEFAFNMKKDEVCVNPyHyQRVEtPVLPPVLVPRHTEIP |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| P98175 | Y694 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | QPISSLRDDERREsAtADAGyAILEKKGALAERQHTsMDLP |
| Q00005 | S71 | Sugiyama | PPP2R2B | FQREQESKNQVHRRGEyNVystFQsHEPEFDyLKSLEIEEK |
| Q00005 | Y67 | Sugiyama | PPP2R2B | RVVIFQREQESKNQVHRRGEyNVystFQsHEPEFDyLKSLE |
| Q00005 | Y70 | Sugiyama | PPP2R2B | IFQREQESKNQVHRRGEyNVystFQsHEPEFDyLKSLEIEE |
| Q00005 | Y82 | Sugiyama | PPP2R2B | HRRGEyNVystFQsHEPEFDyLKSLEIEEKINKIRWLPQQN |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00341 | Y40 | Sugiyama | HDLBP HBP VGL | VPQQIKVAtLNsEEEsDPPtyKDAFPPLPEKAACLESAQEP |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00610 | Y900 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACVA |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00653 | Y247 | Sugiyama | NFKB2 LYT10 | NLKISRMDKTAGSVRGGDEVyLLCDKVQKDDIEVRFYEDDE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | S208 | Sugiyama | SRSF2 SFRS2 | RsRsPPPVsKRESKSRSRsKsPPKsPEEEGAVss_______ |
| Q01130 | S212 | Sugiyama | SRSF2 SFRS2 | PPPVsKRESKSRSRsKsPPKsPEEEGAVss___________ |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q01469 | Y22 | Sugiyama | FABP5 | ATVQQLEGRWRLVDSKGFDEyMKELGVGIALRKMGAMAKPD |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q04637 | Y596 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | SKEDKIHNAENIQPGEQKyEyKsDQWKPLNLEEKKRYDREF |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y20 | Sugiyama | YWHAH YWHA1 | _MGDREQLLQRARLAEQAERyDDMAsAMKAVtELNEPLsNE |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06124 | Y304 | SIGNOR | PTPN11 PTP2C SHPTP2 | PFDHTRVVLHDGDPNEPVSDyINANIIMPEFETKCNNSKPK |
| Q06124 | Y327 | SIGNOR | PTPN11 PTP2C SHPTP2 | ANIIMPEFETKCNNSKPKKSyIATQGCLQNTVNDFWRMVFQ |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07157 | Y1059 | Sugiyama | TJP1 ZO1 | yEPQLPYVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLR |
| Q07157 | Y1066 | Sugiyama | TJP1 ZO1 | VEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVPM |
| Q07157 | Y1354 | Sugiyama | TJP1 ZO1 | LKPPEDIVRSNHyDPEEDEEyyRKQLsyFDRRsFENKPPAH |
| Q07157 | Y1355 | Sugiyama | TJP1 ZO1 | KPPEDIVRSNHyDPEEDEEyyRKQLsyFDRRsFENKPPAHI |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q08378 | Y512 | Sugiyama | GOLGA3 | EAKNAsLAssNNDLQVAEEQyQRLMAKVEDMQRSMLSKDNT |
| Q09028 | Y154 | Sugiyama | RBBP4 RBAP48 | PQNPCIIATKtPssDVLVFDyTKHPsKPDPsGECNPDLRLR |
| Q12874 | Y50 | Sugiyama | SF3A3 SAP61 | KSTLRDQINSDHRTRAMQDRyMEVSGNLRDLyDDKDGLRKE |
| Q12888 | Y522 | Sugiyama | TP53BP1 | EDLGLsLtGDsCKLMLstsEysQsPKMEsLssHRIDEDGEN |
| Q12904 | Y24 | Sugiyama | AIMP1 EMAP2 SCYE1 | NDAVLKRLEQKGAEADQIIEyLKQQVSLLKEKAILQATLRE |
| Q12931 | Y498 | Sugiyama | TRAP1 HSP75 HSPC5 | GQLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyyEAMK |
| Q12931 | Y499 | Sugiyama | TRAP1 HSP75 HSPC5 | QLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyyEAMKK |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12931 | Y514 | Sugiyama | TRAP1 HSP75 HSPC5 | tRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDEL |
| Q13017 | Y1109 | Sugiyama | ARHGAP5 RHOGAP5 | DNyAEPIDTIFKQKGYsDEIyVVPDDsQNRIKIRNsFVNNt |
| Q13066 | Y16 | Sugiyama | GAGE2B GAGE2; GAGE2C | _____MSWRGRSTYRPRPRRyVEPPEMIGPMRPEQFsDEVE |
| Q13069 | Y10 | Sugiyama | GAGE5 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13070 | Y10 | Sugiyama | GAGE6 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13153 | Y153 | EPSD|PSP | PAK1 | sKKTSNSQKYMsFtDKsAEDyNssNALNVKAVsETPAVPPV |
| Q13153 | Y201 | EPSD|PSP | PAK1 | DDDAtPPPVIAPRPEHTKsVytRsVIEPLPVtPtRDVAtsP |
| Q13153 | Y285 | EPSD|PSP | PAK1 | DPKKKYTRFEKIGQGASGTVyTAMDVAtGQEVAIKQMNLQQ |
| Q13162 | Y54 | Sugiyama | PRDX4 | AVQGWETEERPRTREEECHFyAGGQVyPGEAsRVsVADHsL |
| Q13190 | Y265 | Sugiyama | STX5 STX5A | IDMMDSRTSQQLQLIDEQDsyIQSRADTMQNIESTIVELGS |
| Q13200 | Y439 | Sugiyama | PSMD2 TRAP2 | LWDVDGGLTQIDKyLySsEDyIKSGALLACGIVNSGVRNEC |
| Q13228 | Y28 | Sugiyama | SELENBP1 SBP | CGPGySTPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVD |
| Q13228 | Y33 | Sugiyama | SELENBP1 SBP | STPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVDVDPKs |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | T21 | Sugiyama | G3BP1 G3BP | MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssyV |
| Q13283 | Y363 | Sugiyama | G3BP1 G3BP | FIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGFV |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13509 | S338 | Sugiyama | TUBB3 TUBB4 | RGRMSMKEVDEQMLAIQSKNssyFVEWIPNNVKVAVCDIPP |
| Q13546 | Y384 | Sugiyama | RIPK1 RIP RIP1 | EHPQEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVA |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13573 | Y260 | Sugiyama | SNW1 SKIIP SKIP | KEQQEWKIPPCISNWKNAKGytIPLDKRLAADGRGLQTVHI |
| Q13596 | Y162 | Sugiyama | SNX1 | QFDLTVGITDPEKIGDGMNAyVAyKVTTQTsLPLFRSKQFA |
| Q13596 | Y165 | Sugiyama | SNX1 | LTVGITDPEKIGDGMNAyVAyKVTTQTsLPLFRSKQFAVKR |
| Q13601 | Y287 | Sugiyama | KRR1 HRB2 | tPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKAKQA |
| Q13620 | Y413 | Sugiyama | CUL4B KIAA0695 | TNRLYAAEGQKLMQEREVPEyLHHVNKRLEEEADRLITYLD |
| Q13642 | Y117 | Sugiyama | FHL1 SLIM1 | DsPKCKGCFKAIVAGDQNVEyKGtVWHKDCFTCSNCKQVIG |
| Q13642 | Y149 | Sugiyama | FHL1 SLIM1 | CSNCKQVIGtGSFFPKGEDFyCVtCHETKFAKHCVKCNKAI |
| Q13885 | S338 | Sugiyama | TUBB2A TUBB2 | RGRMsMKEVDEQMLNVQNKNssyFVEWIPNNVKTAVCDIPP |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14157 | Y858 | Sugiyama | UBAP2L KIAA0144 NICE4 | PFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATT |
| Q14192 | Y154 | Sugiyama | FHL2 DRAL SLIM3 | QPIGTKSFIPKDNQNFCVPCyEKQHAMQCVQCKKPITTGGV |
| Q14192 | Y97 | Sugiyama | FHL2 DRAL SLIM3 | DKPFAAKEDQLLCTDCySNEySSKCQECKKTIMPGTRKMEY |
| Q14203 | Y513 | Sugiyama | DCTN1 | GARVREAQKRVEAAQEtVADyQQTIKKYRQLtAHLQDVNRE |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y141 | Sugiyama | CTTN EMS1 | FGGKFGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGK |
| Q14247 | Y178 | Sugiyama | CTTN EMS1 | FGGKyGVQADRVDKsAVGFDyQGKTEKHESQRDYSKGFGGK |
| Q14247 | Y215 | Sugiyama | CTTN EMS1 | FGGKyGIDKDKVDKsAVGFEyQGKtEKHESQKDyVKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14457 | Y333 | SIGNOR|PSP | BECN1 GT197 | LLHALANKMGLKFQRYRLVPyGNHsYLESLTDKSKELPLyC |
| Q14566 | Y111 | Sugiyama | MCM6 | CRALKTFVKDRKEIPLAKDFyVAFQDLPTRHKIRELTSSRI |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14676 | Y775 | Sugiyama | MDC1 KIAA0170 NFBD1 | FCLREsEDsEtQPFDtHLEAyGPCLsPPRAIPGDQHPEsPV |
| Q14696 | Y58 | Sugiyama | MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 | PGTPDESTPPPRKKKKDIRDyNDADMARLLEQWEKDDDIEE |
| Q14697 | Y489 | Sugiyama | GANAB G2AN KIAA0088 | PHIKVDSGyRVHEELRNLGLyVKtRDGSDyEGWCWPGSAGY |
| Q14697 | Y60 | Sugiyama | GANAB G2AN KIAA0088 | tCEEssFCKRQRsIRPGLsPyRALLDSLQLGPDSLTVHLIH |
| Q14765 | Y693 | SIGNOR|ELM | STAT4 | KHYSSQPCEVSRPTERGDKGyVPSVFIPISTIRSDSTEPHs |
| Q14C86 | Y86 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | SPAECCQHAKILEDTQFVDGyKQLGFQETAYGEFLSRLREN |
| Q15019 | Y211 | Sugiyama | SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2 | ERERLKKRILDEIEEHNIKIyHLPDAEsDEDEDFKEQtRLL |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15067 | Y239 | Sugiyama | ACOX1 ACOX | PGITVGDIGPKFGyDEIDNGyLKMDNHRIPRENMLMKYAQV |
| Q15118 | Y243 | EPSD|PSP | PDK1 PDHK1 | CNVLEVIKDGYENARRLCDLyyINSPELELEELNAKSPGQP |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15181 | Y28 | Sugiyama | PPA1 IOPPP PP | ERAAPFsLEyRVFLKNEKGQyIsPFHDIPIyADKDVFHMVV |
| Q15181 | Y38 | Sugiyama | PPA1 IOPPP PP | RVFLKNEKGQyIsPFHDIPIyADKDVFHMVVEVPRWSNAKM |
| Q15181 | Y90 | Sugiyama | PPA1 IOPPP PP | KQDVKKGKLRyVANLFPyKGyIWNyGAIPQtWEDPGHNDKH |
| Q15181 | Y94 | Sugiyama | PPA1 IOPPP PP | KKGKLRyVANLFPyKGyIWNyGAIPQtWEDPGHNDKHTGCC |
| Q15293 | Y115 | Sugiyama | RCN1 RCN | GDGFVttEELKtWIKRVQKRyIFDNVAKVWKDYDRDKDDKI |
| Q15293 | Y147 | Sugiyama | RCN1 RCN | YDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKM |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15555 | Y268 | Sugiyama | MAPRE2 RP1 | NEQVHsLKLALEGVEKERDFyFGKLREIELLCQEHGQENDD |
| Q15642 | Y590 | Sugiyama | TRIP10 CIP4 STOT STP | MEEDKGDGWTRVRRKEGGEGyVPtsyLRVTLN_________ |
| Q15642 | Y595 | Sugiyama | TRIP10 CIP4 STOT STP | GDGWTRVRRKEGGEGyVPtsyLRVTLN______________ |
| Q15648 | S1493 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | EKsyQNsPssDDGIRPLPEYstEKHKKHKKEKKKVKDKDRD |
| Q15654 | Y131 | Sugiyama | TRIP6 OIP1 | RGHASRRPDRQAyEPPPPPAyRtGsLKPNPAsPLPAsPyGG |
| Q15691 | Y217 | Sugiyama | MAPRE1 | MQQVNVLKLtVEDLEKERDFyFGKLRNIELICQENEGENDP |
| Q15796 | Y165 | Sugiyama | SMAD2 MADH2 MADR2 | AIENCEyAFNLKKDEVCVNPyHyQRVEtPVLPPVLVPRHTE |
| Q15796 | Y167 | Sugiyama | SMAD2 MADH2 MADR2 | ENCEyAFNLKKDEVCVNPyHyQRVEtPVLPPVLVPRHTEIL |
| Q15910 | Y641 | SIGNOR|EPSD|PSP | EZH2 KMT6 | VAGWGIFIKDPVQKNEFISEyCGEIISQDEADRRGKVYDKY |
| Q16513 | Y979 | Sugiyama | PKN2 PRK2 PRKCL2 | PPREPRILsEEEQEMFRDFDyIADWC_______________ |
| Q16576 | Y153 | Sugiyama | RBBP7 RBAP46 | PQNPHIIATKtPssDVLVFDyTKHPAKPDPsGECNPDLRLR |
| Q16595 | Y95 | Sugiyama | FXN FRDA X25 | LMNLRKsGtLGHPGsLDEttyERLAEETLDSLAEFFEDLAD |
| Q16643 | Y163 | Sugiyama | DBN1 D0S117E | PVLHRLRLREDENAEPVGttyQKTDAAVEMKRINREQFWEQ |
| Q16658 | Y230 | Sugiyama | FSCN1 FAN1 HSN SNL | TGytLEFRsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGK |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16851 | Y89 | Sugiyama | UGP2 UGP1 | KGPSVDWGKIQRPPEDSIQPyEKIKARGLPDNISsVLNKLV |
| Q32MZ4 | Y597 | Sugiyama | LRRFIP1 GCF2 TRIP | KKKKsPVPVETLKDVKKELtyQNTDLsEIKEEEQVKstDRK |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5SW79 | Y532 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | EEVEARKMIDKVFGVDDNQDyNRPVINEKHKDLIKDWALss |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5VT52 | Y1090 | Sugiyama | RPRD2 KIAA0460 HSPC099 | sCLDLPDSTEEKGAPIETLGyHsASNRRMsGEPIQTVESIR |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q66LE6 | S81 | Sugiyama | PPP2R2D KIAA1541 | FQREQENKSRPHSRGEyNVystFQsHEPEFDyLKSLEIEEK |
| Q66LE6 | Y77 | Sugiyama | PPP2R2D KIAA1541 | RVVIFQREQENKSRPHSRGEyNVystFQsHEPEFDyLKSLE |
| Q66LE6 | Y80 | Sugiyama | PPP2R2D KIAA1541 | IFQREQENKSRPHSRGEyNVystFQsHEPEFDyLKSLEIEE |
| Q66LE6 | Y92 | Sugiyama | PPP2R2D KIAA1541 | HSRGEyNVystFQsHEPEFDyLKSLEIEEKINKIRWLPQQN |
| Q6FI81 | Y278 | Sugiyama | CIAPIN1 CUA001 PRO0915 | EKEKSREQMSSQPKsACGNCyLGDAFRCAsCPyLGMPAFKP |
| Q6L8Q7 | Y235 | Sugiyama | PDE12 | sLsPssPsssWtEtDVEERVytPSNADIGLRLKLHCTPGDG |
| Q6N021 | Y1939 | SIGNOR|PSP | TET2 KIAA1546 Nbla00191 | AKMAEKAREKEEECEKYGPDyVPQKSHGKKVKREPAEPHET |
| Q6N021 | Y1964 | SIGNOR|PSP | TET2 KIAA1546 Nbla00191 | SHGKKVKREPAEPHETSEPTyLRFIKSLAERTMSVTTDSTV |
| Q6NT46 | Y16 | Sugiyama | GAGE2A GAGE2 | _____MSWRGRSTYRPRPRRyVEPPEMIGPMRPEQFsDEVE |
| Q6PEY2 | T225 | Sugiyama | TUBA3E | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| Q6PKG0 | Y361 | Sugiyama | LARP1 KIAA0731 LARP | GRGRGRGRGRGRGGTRtHFDyQFGyRKFDGVEGPRtPKYMN |
| Q6PKG0 | Y365 | Sugiyama | LARP1 KIAA0731 LARP | GRGRGRGRGGTRtHFDyQFGyRKFDGVEGPRtPKYMNNITY |
| Q6PKG0 | Y699 | Sugiyama | LARP1 KIAA0731 LARP | INDGLFyyEQDLWAEKFEPEysQIKQEVENFKKVNMISREQ |
| Q6PKG0 | Y777 | Sugiyama | LARP1 KIAA0731 LARP | APEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDSSQT |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6WCQ1 | Y718 | Sugiyama | MPRIP KIAA0864 MRIP RHOIP3 | RLLQDQLRVALGREQSAREGyVLQATCERGFAAMEETHQKK |
| Q6WKZ4 | Y1254 | Sugiyama | RAB11FIP1 RCP | VLKQKETISKKEFQVRELEDyIDNLLVRVMEETPNILRIPT |
| Q71RC2 | Y425 | Sugiyama | LARP4 PP13296 | SRNFPAERHNPTVTGHQEQtyLQKETSTLQVEQNGDYGRGR |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | T225 | Sugiyama | TUBA1A TUBA3 | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| Q71U36 | Y312 | Sugiyama | TUBA1A TUBA3 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | Y109 | Sugiyama | SND1 TDRD11 | KLIGKEVCFtIENKtPQGREyGMIyLGKDTNGENIAEsLVA |
| Q7KZF4 | Y113 | Sugiyama | SND1 TDRD11 | KEVCFtIENKtPQGREyGMIyLGKDTNGENIAEsLVAEGLA |
| Q7L804 | Y480 | Sugiyama | RAB11FIP2 KIAA0941 | LVKHKELLRRKDTHIRELEDyIDNLLVRVMEETPSILRVPY |
| Q7Z2W4 | Y299 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | IsHRAsLEDAPVDDLtRKFtyLGsQDRARPPsGsSKATDLG |
| Q7Z3K3 | Y33 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | EELEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQPVSAPV |
| Q7Z417 | Y686 | Sugiyama | NUFIP2 KIAA1321 PIG1 | TKEMEsIWNLQKQDPKRIItyNEAMDsPDQ___________ |
| Q7Z460 | Y525 | Sugiyama | CLASP1 KIAA0622 MAST1 | EARKCYWGFHSHFSREAEHLyHTLESSyQKALQSHLKNSDs |
| Q7Z460 | Y532 | Sugiyama | CLASP1 KIAA0622 MAST1 | GFHSHFSREAEHLyHTLESSyQKALQSHLKNSDsIVsLPQs |
| Q7Z4V5 | Y18 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | ___MPHAFKPGDLVFAKMKGyPHWPARIDDIADGAVKPPPN |
| Q7Z5J4 | Y334 | Sugiyama | RAI1 KIAA1820 | YGQQGQGYCQPDAAVRTPEQyyQtFsPsssHsPARSVGRSP |
| Q7Z5J4 | Y335 | Sugiyama | RAI1 KIAA1820 | GQQGQGYCQPDAAVRTPEQyyQtFsPsssHsPARSVGRSPS |
| Q86TX2 | Y289 | Sugiyama | ACOT1 CTE1 | GETLPPVGVNRNRIKVTKDGyADIVDVLNsPLEGPDQKSFI |
| Q86UU0 | Y266 | Sugiyama | BCL9L DLNB11 | HLANTAAEAVLQGRADSILAyHQQNVPRAKLDQAPKVPPTP |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86VS8 | Y171 | Sugiyama | HOOK3 | MTAIQELMSKEsPVSAGNDAyVDLDRQLKKTTEELNEALSA |
| Q8IWA5 | Y308 | Sugiyama | SLC44A2 CTL2 PSEC0210 | GEAGSDVSLVDLGFQTDFRVyLHLRQTWLAFMIILSILEVI |
| Q8IZP0 | Y23 | Sugiyama | ABI1 SSH3BP1 | ELQMLLEEEIPSGKRALIEsyQNLTRVADyCENNyIQATDK |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y133 | Sugiyama | PGAM4 PGAM3 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSY |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N6H7 | Y278 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | QAADAKKQAEESMVASMRLAyQELQIDRKKEEKKLQNLEGK |
| Q8N6T3 | Y175 | Sugiyama | ARFGAP1 ARF1GAP | sVtAssDKAFEDWLNDDLGsyQGAQGNRyVGFGNtPPPQKK |
| Q8NBF2 | Y39 | Sugiyama | NHLRC2 | TSLEYALLDAVTQQEKDSLVyQyLQKVDGWEQDLSVPEFPE |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NBS9 | Y289 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | RDGKKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSE |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NFI4 | Y185 | Sugiyama | ST13P5 FAM10A5 | NAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WUA2 | Y401 | Sugiyama | PPIL4 | TSKKHKKKTHHCsEEKEDEDyMPIKNTNQDIYREMGFGHYE |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WWM7 | S276 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | MFKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRELRA |
| Q8WWM7 | Y270 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | GWDPNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFR |
| Q8WX93 | Y731 | Sugiyama | PALLD KIAA0992 CGI-151 | PMSALASRsAPAMQssGsFNyARPKQFIAAQNLGPAsGHGt |
| Q8WXF1 | Y275 | Sugiyama | PSPC1 PSP1 | YHKEREQPPRFAQPGTFEFEyASRWKALDEMEKQQREQVDR |
| Q92734 | Y392 | Sugiyama | TFG | tPPPSGPNPYARNRPPFGQGytQPGPGyR____________ |
| Q92734 | Y399 | Sugiyama | TFG | NPYARNRPPFGQGytQPGPGyR___________________ |
| Q92858 | Y80 | SIGNOR | ATOH1 ATH1 BHLHA14 | DPRAWLAPTLQGICTARAAQyLLHsPELGASEAAAPRDEVD |
| Q92882 | Y207 | Sugiyama | OSTF1 | sLLKKKQGTDAVRtLsNAEDyLDDEDsD_____________ |
| Q92888 | Y738 | GPS6|SIGNOR|EPSD|PSP | ARHGEF1 | VATDHKAFYVLFTWDQEAQIyELVAQTVSERKNWCALITET |
| Q92900 | T1124 | Sugiyama | UPF1 KIAA0221 RENT1 | VALsQDstyQGERAyQHGGVtGLsQy_______________ |
| Q92900 | Y1118 | Sugiyama | UPF1 KIAA0221 RENT1 | FKsQIDVALsQDstyQGERAyQHGGVtGLsQy_________ |
| Q92945 | T645 | Sugiyama | KHSRP FUBP2 | yyKKIGQQPQQPGAPPQQDytKAWEEYYKKQAQVATGGGPG |
| Q92945 | Y625 | Sugiyama | KHSRP FUBP2 | GEPPQPPPTGQSDYTKAWEEyyKKIGQQPQQPGAPPQQDyt |
| Q92945 | Y644 | Sugiyama | KHSRP FUBP2 | EyyKKIGQQPQQPGAPPQQDytKAWEEYYKKQAQVATGGGP |
| Q93052 | Y300 | Sugiyama | LPP | GLQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQ |
| Q93052 | Y301 | Sugiyama | LPP | LQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQG |
| Q96A49 | Y327 | Sugiyama | SYAP1 PRO3113 | AVLEEDsADWEKELQQELQEyEVVtESEKRDENWDKEIEKM |
| Q96AC1 | Y673 | Sugiyama | FERMT2 KIND2 MIG2 PLEKHC1 | YIFLSTRAKDQNEsLDEEMFyKLTSGWV_____________ |
| Q96AE4 | Y589 | Sugiyama | FUBP1 | GDQQNPAPAGQVDYTKAWEEyyKKMGQAVPAPTGAPPGGQP |
| Q96AE4 | Y625 | Sugiyama | FUBP1 | PGGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ_ |
| Q96AE4 | Y626 | Sugiyama | FUBP1 | GGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ__ |
| Q96B26 | Y13 | Sugiyama | EXOSC8 OIP2 RRP43 | ________MAAGFKTVEPLEyyRRFLKENCRPDGRELGEFR |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96IK1 | Y82 | Sugiyama | BOD1 FAM44B | RGLFDSFRRDCLADVDTKPAyQNLRQKVDNFVStHLDKQEW |
| Q96KB5 | Y74 | PSP | PBK TOPK | RGLsHsPWAVKKINPICNDHyRsVYQKRLMDEAKILKsLHH |
| Q96Q11 | Y430 | Sugiyama | TRNT1 CGI-47 | QLREQWKKSGYQMEKDELLSyIKKT________________ |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q96RP9 | Y717 | Sugiyama | GFM1 EFG EFG1 GFM | FGYSTELRSCTEGKGEYTMEySRyQPCLPStQEDVINKYLE |
| Q96RP9 | Y720 | Sugiyama | GFM1 EFG EFG1 GFM | STELRSCTEGKGEYTMEySRyQPCLPStQEDVINKYLEATG |
| Q99459 | Y459 | Sugiyama | CDC5L KIAA0432 PCDC5RP | PGRtPLRDKLNINPEDGMADysDPsyVKQMERESREHLRLG |
| Q99459 | Y464 | Sugiyama | CDC5L KIAA0432 PCDC5RP | LRDKLNINPEDGMADysDPsyVKQMERESREHLRLGLLGLP |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99471 | Y90 | Sugiyama | PFDN5 MM1 PFD5 | MYVPGKLHDVEHVLIDVGtGyyVEKTAEDAKDFFKRKIDFL |
| Q99471 | Y91 | Sugiyama | PFDN5 MM1 PFD5 | YVPGKLHDVEHVLIDVGtGyyVEKTAEDAKDFFKRKIDFLT |
| Q99536 | T242 | Sugiyama | VAT1 | SASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMD |
| Q99536 | T243 | Sugiyama | VAT1 | ASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMDP |
| Q99536 | Y240 | Sugiyama | VAT1 | TASASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIV |
| Q99536 | Y245 | Sugiyama | VAT1 | KHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMDPLG |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99543 | Y274 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | TRAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAE |
| Q99613 | Y884 | Sugiyama | EIF3C EIF3S8 | GsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRRGGY |
| Q99614 | Y280 | Sugiyama | TTC1 TPR1 | RPFGLstENFQIKQDsstGsysINFVQNPNNNR________ |
| Q99683 | Y718 | SIGNOR|EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | RDLSNQVRIAIKEIPERDSRySQPLHEEIALHKHLKHKNIV |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y513 | Sugiyama | ACO2 | PEIVTALAIAGTLKFNPEtDyLTGtDGKKFRLEAPDADELP |
| Q99798 | Y544 | Sugiyama | ACO2 | LEAPDADELPKGEFDPGQDtyQHPPKDSsGQHVDVsPtsQR |
| Q99961 | Y57 | Sugiyama | SH3GL1 CNSA1 SH3D2B | EKKVDVTSKAVTEVLARTIEyLQPNPAsRAKLTMLNTVSKI |
| Q99962 | Y57 | Sugiyama | SH3GL2 CNSA2 SH3D2A | ERKVDVTSRAVMEIMTKTIEyLQPNPAsRAKLSMINTMsKI |
| Q9BPX3 | Y929 | Sugiyama | NCAPG CAPG NYMEL3 | QDATLTTTTFQNEDEKNKEVyMtPLRGVKATQASKSTQLKT |
| Q9BQE3 | T225 | Sugiyama | TUBA1C TUBA6 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| Q9BQE3 | Y312 | Sugiyama | TUBA1C TUBA6 | TNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRS2 | Y83 | Sugiyama | RIOK1 RIO1 | YDDDDDDWDWDEGVGKLAKGyVWNGGsNPQANRQTSDSSSA |
| Q9BS26 | T398 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | VASSPPESSFQKLAPsEyRytLLRDRDEL____________ |
| Q9BS26 | Y135 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | NGMMMKREYRGQRSVKALADyIRQQKSDPIQEIRDLAEItt |
| Q9BS26 | Y395 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | AQDVASSPPESSFQKLAPsEyRytLLRDRDEL_________ |
| Q9BS26 | Y397 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | DVASSPPESSFQKLAPsEyRytLLRDRDEL___________ |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BSU3 | Y145 | Sugiyama | NAA11 ARD1B ARD2 | TLNFQISEVEPKyyADGEDAyAMKRDLSQMADELRRQMDLK |
| Q9BTT0 | Y92 | Sugiyama | ANP32E | SDNIISGGLEVLAEKCPNLTyLNLSGNKIKDLsTVEALQNL |
| Q9BU89 | Y290 | Sugiyama | DOHH HLRC1 | RESCEVALDMyEHETGRAFQyADGLEQLRGAPS________ |
| Q9BUF5 | S338 | Sugiyama | TUBB6 | RGPMSMKEVDEQMLAIQSKNssyFVEWIPNNVKVAVCDIPP |
| Q9BUP3 | Y62 | Sugiyama | HTATIP2 CC3 TIP30 | GLFSKVTLIGRRKLTFDEEAyKNVNQEVVDFEKLDDYASAF |
| Q9BVA0 | Y382 | Sugiyama | KATNB1 | SSEDDRDERESRAEIQNAEDyNEIFQPKNSISRtPPRRsEP |
| Q9BVA1 | S338 | Sugiyama | TUBB2B | RGRMsMKEVDEQMLNVQNKNssyFVEWIPNNVKTAVCDIPP |
| Q9BXS5 | Y134 | Sugiyama | AP1M1 CLTNM | LDELMDFGYPQTTDSKILQEyITQEGHKLEtGAPRPPAtVt |
| Q9BXS5 | Y418 | Sugiyama | AP1M1 CLTNM | IEKSGYQALPWVRYITQNGDyQLRtQ_______________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9C0C2 | Y897 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ssRDVsLGDWEFGKRDsLGAyAsQDANEQGQDLGKRDHHGR |
| Q9C0C2 | Y961 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GSRAAEPQEQEFGKSAWIRDyssGGsSRtLDAQDRsFGtRP |
| Q9C0C9 | Y355 | Sugiyama | UBE2O KIAA1734 | RVKRLGCFDHAQRQLGERCLyVFPAKVEPAKIAWECPEKNC |
| Q9H2H8 | Y141 | Sugiyama | PPIL3 | VIDGLETLDELEKLPVNEKtyRPLNDVHIKDItIHANPFAQ |
| Q9H2H8 | Y75 | Sugiyama | PPIL3 | DPTGTGRGGNSIWGKKFEDEysEyLKHNVRGVVSMANNGPN |
| Q9H2H8 | Y78 | Sugiyama | PPIL3 | GTGRGGNSIWGKKFEDEysEyLKHNVRGVVSMANNGPNTNG |
| Q9H2U1 | Y169 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | NQEKKMFRIRNRsyIDRDsEyLLQENEPDGtLDQKLLEDLQ |
| Q9H3G5 | Y329 | Sugiyama | CPVL VLP PSEC0124 UNQ197/PRO223 | TGCSNYYNFLRCTEPEDQLyyVKFLsLPEVRQAIHVGNQTF |
| Q9H788 | Y131 | Sugiyama | SH2D4A PPP1R38 SH2A | EEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKVAE |
| Q9H788 | Y449 | Sugiyama | SH2D4A PPP1R38 SH2A | TSLGKELLLYPCGQQDQLPDyLELFE_______________ |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9H7N4 | Y238 | Sugiyama | SCAF1 SFRS19 SRA1 | PAPPAPRFDIYDPFHPtDEAysPPPAPEQKYDPFEPTGSNP |
| Q9H814 | Y309 | Sugiyama | PHAX RNUXA | FLNLLKNtPsISEEQIKDIFyIENQKEYENKKAARKRRTQV |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HAV0 | Y145 | Sugiyama | GNB4 | NLKTREGNVRVsRELPGHtGyLSCCRFLDDSQIVTSSGDTT |
| Q9HB07 | Y189 | Sugiyama | MYG1 C12orf10 | VEEVDAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHP |
| Q9HB71 | Y165 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | VKTDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEt |
| Q9HCC0 | Y520 | Sugiyama | MCCC2 MCCB | ADEAALKEPIIKKFEEEGNPyySsARVWDDGIIDPADTRLV |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9HDC5 | Y417 | Sugiyama | JPH1 JP1 | AARQECDIARAVARELsPDFyQPGPDyVKQRFQEGVDAKEN |
| Q9HDC5 | Y423 | Sugiyama | JPH1 JP1 | DIARAVARELsPDFyQPGPDyVKQRFQEGVDAKENPEEKVP |
| Q9NNW7 | Y70 | Sugiyama | TXNRD2 KIAA1652 TRXR2 | GGLACAKEAAQLGRKVAVVDyVEPSPQGTRWGLGGTCVNVG |
| Q9NP61 | Y432 | Sugiyama | ARFGAP3 ARFGAP1 | ENTDEAQKKFGNVKAIssDMyFGRQsQADYETRARLERLsA |
| Q9NQC3 | Y1165 | Sugiyama | RTN4 KIAA0886 NOGO My043 SP1507 | LISLFSVPVIYERHQAQIDHyLGLANKNVKDAMAKIQAKIP |
| Q9NQC3 | Y889 | Sugiyama | RTN4 KIAA0886 NOGO My043 SP1507 | DEFPTLISSKTDSFSKLAREyTDLEVSHKSEIANAPDGAGS |
| Q9NQW7 | Y588 | Sugiyama | XPNPEP1 XPNPEPL XPNPEPL1 | QTKMIDVDSLTDKECDWLNNyHLtCRDVIGKELQKQGRQEA |
| Q9NR56 | Y68 | Sugiyama | MBNL1 EXP KIAA0428 MBNL | GRVIACFDsLKGRCSRENCKyLHPPPHLKTQLEINGRNNLI |
| Q9NRF2 | Y439 | GPS6 | SH2B1 KIAA1299 SH2B | PSQDLLLGPSESNDRLSQGAyGGLSDRPSASISPSSASIAA |
| Q9NRF2 | Y494 | GPS6 | SH2B1 KIAA1299 SH2B | PRIPIEEGPPTGTVHPLSAPyPPLDTPETATGSFLFQGEPE |
| Q9NUK0 | Y69 | Sugiyama | MBNL3 CHCR MBLX39 MBXL | GRVVACFDSLKGRCTRENCKyLHPPPHLKTQLEINGRNNLI |
| Q9NVR5 | Y697 | Sugiyama | DNAAF2 C14orf104 KTU | DQLQGKEERVNEESHLTEKEyIEHCNtPttDSDSSIAVKAL |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NY65 | T225 | Sugiyama | TUBA8 TUBAL2 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| Q9NYB9 | T24 | Sugiyama | ABI2 ARGBPIA | LQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSADKQ |
| Q9NYF8 | Y408 | Sugiyama | BCLAF1 BTF KIAA0164 | EsGKQKFNDsEGDDtEEtEDyRQFRKsVLADQGKsFATAsH |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9NZB2 | Y9 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | ____________MGVQGFQDyIEKHCPsAVVPVELQKLARG |
| Q9P0J1 | Y381 | Sugiyama | PDP1 PDP PPM2C | SIDLQKRVIESGPDQLNDNEytKFIPPNYHTPPYLTAEPEV |
| Q9P0J1 | Y94 | SIGNOR | PDP1 PDP PPM2C | TPQKFyLTPPQVNSILKANEySFKVPEFDGKNVSSILGFDs |
| Q9P0P0 | T153 | Sugiyama | RNF181 HSPC238 | DKARKQQQQHRLENLHGAMyt____________________ |
| Q9P0P0 | Y152 | Sugiyama | RNF181 HSPC238 | RDKARKQQQQHRLENLHGAMyt___________________ |
| Q9P2B2 | Y513 | Sugiyama | PTGFRN CD9P1 EWIF FPRP KIAA1436 | EHTDtFNFRIQRTTEEDRGNyyCVVSAWTKQRNNSWVKSKD |
| Q9P2B2 | Y514 | Sugiyama | PTGFRN CD9P1 EWIF FPRP KIAA1436 | HTDtFNFRIQRTTEEDRGNyyCVVSAWTKQRNNSWVKSKDV |
| Q9UBQ7 | Y255 | Sugiyama | GRHPR GLXR MSTP035 | KETAVFINISRGDVVNQDDLyQALAsGKIAAAGLDVtsPEP |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y74 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | PDRNPDDPQAQEKFQDLGAAyEVLsDSEKRKQyDTyGEEGL |
| Q9UBU9 | Y435 | Sugiyama | NXF1 TAP | CCSLSIPFIPQNPARSsLAEyFKDSRNVKKLKDPTLRFRLL |
| Q9UGI8 | Y126 | Sugiyama | TES | INTVtyEWAPPVQNQALARQyMQMLPKEKQPVAGsEGAQYR |
| Q9UGK3 | Y22 | EPSD|PSP | STAP2 BKS | ASALRPPRVPKPKGVLPSHYyESFLEKKGPCDRDYKKFWAG |
| Q9UGK3 | Y250 | SIGNOR|iPTMNet|EPSD|PSP | STAP2 BKS | VNYFVSHTKKALVPFLLDEDyEKVLGYVEADKENGENVWVA |
| Q9UGK3 | Y310 | SIGNOR|iPTMNet|EPSD|PSP | STAP2 BKS | PASsQDKLPPLPPLPNQEENyVTPIGDGPAVDyENQDVASS |
| Q9UGK3 | Y322 | EPSD|PSP | STAP2 BKS | PLPNQEENyVTPIGDGPAVDyENQDVASSSWPVILKPKKLP |
| Q9UHD1 | Y26 | Sugiyama | CHORDC1 CHP1 | YNRGCGQRFDPETNsDDACtyHPGVPVFHDALKGWSCCKRR |
| Q9UHI6 | T590 | Sugiyama | DDX20 DP103 GEMIN3 | VSLPQIPCLSSFKIHQPyTLtFAELVEDYEHyIKEGLEKPV |
| Q9UHI6 | Y601 | Sugiyama | DDX20 DP103 GEMIN3 | FKIHQPyTLtFAELVEDYEHyIKEGLEKPVEIIRHYTGPGD |
| Q9UHX1 | Y296 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | KAQSSQDAVSSMNLFDLGGQyLRVGKAVTPPMPLLtPAtPG |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UII2 | Y58 | Sugiyama | ATP5IF1 ATPI ATPIF1 | GsIREAGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEI |
| Q9UIQ6 | Y70 | Sugiyama | LNPEP OTASE | GsRLLVRGLGEHEMEEDEEDyEssAKLLGMsFMNRssGLRN |
| Q9UJU6 | Y16 | Sugiyama | DBNL CMAP SH3P7 PP5423 | _____MAANLSRNGPALQEAyVRVVtEKsPtDWALFTyEGN |
| Q9UKX7 | Y193 | Sugiyama | NUP50 NPAP60L PRO1146 | KHVNTNPLCDLTPIFKDYEKyLANIEQQHGNsGRNsESEsN |
| Q9ULX6 | Y435 | Sugiyama | AKAP8L NAKAP NAKAP95 HRIHFB2018 | EHFKYVGTKLPKQTADFLQEyVTNKTKKTEELRKTVEDLDG |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UN86 | Y125 | Sugiyama | G3BP2 KIAA0660 | ERKFMQTFVLAPEGSVPNKFyVHNDMFRYEDEVFGDsEPEL |
| Q9UNH7 | Y220 | Sugiyama | SNX6 | VSGVKDVDDFFEHERTFLLEyHNRVKDASAKSDRMTRSHKS |
| Q9UNP9 | Y300 | Sugiyama | PPIE CYP33 | AQGSKDGKPKQKVIIADCGEyV___________________ |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UNZ2 | Y201 | Sugiyama | NSFL1C UBXN2C | HVVLKLWKsGFsLDNGELRSyQDPsNAQFLEsIRRGEVPAE |
| Q9UPQ0 | Y179 | Sugiyama | LIMCH1 KIAA1102 | QMRKDTDDIEsPKRSIRDsGyIDCWDsERsDsLsPPRHGRD |
| Q9UQC2 | Y643 | SIGNOR|EPSD|PSP | GAB2 KIAA0571 | sPsPHRKPSTssVtSDEKVDyVQVDKEKTQALQNTMQEWTD |
| Q9Y230 | Y446 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | IKRVysLFLDEsRSTQYMKEyQDAFLFNELKGEtMDTS___ |
| Q9Y262 | S414 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | YGDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYDNVHPN |
| Q9Y262 | Y415 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | GDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYDNVHPNY |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2B0 | Y71 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKE |
| Q9Y2B0 | Y92 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ARsEAHLtELLEEICDRMKEyGEQIDPstHRKNYVRVVGRN |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W2 | Y236 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | GRKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDD |
| Q9Y394 | Y330 | Sugiyama | DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448 | NKMGKKRIENFKSGVDADssyFKIFKTKHD___________ |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3E1 | Y22 | Sugiyama | HDGFL3 HDGF2 HDGFRP3 CGI-142 | ARPRPREYKAGDLVFAKMKGyPHWPARIDELPEGAVKPPAN |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3F4 | Y261 | Sugiyama | STRAP MAWD UNRIP | GGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFSPDGELyA |
| Q9Y3S2 | Y253 | Sugiyama | ZNF330 NOA36 | LKFGRQTGGEEGDGASGYDAyWKNLSSDKYGDTSYHDEEED |
| Q9Y450 | Y58 | Sugiyama | HBS1L HBS1 KIAA1038 | AQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQ |
| Q9Y490 | Y1893 | Sugiyama | TLN1 KIAA1027 TLN | TKsNtsPEELGPLANQLTsDyGRLAsEAKPAAVAAENEEIG |
| Q9Y4C1 | Y1101 | SIGNOR | KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA | LNLASRLPNYFVRPDLGPKMyNAYGLITPEDRKyGTTNLHL |
| Q9Y4H2 | S805 | Sugiyama | IRS2 | sAALHPGGEPLRGVPGCCyssLPRSYKAPytCGGDsDQyVL |
| Q9Y4H2 | Y625 | Sugiyama | IRS2 | FsGsAGRLCPsCPAssPKVAyHPyPEDyGDIEIGsHRssss |
| Q9Y4H2 | Y632 | Sugiyama | IRS2 | LCPsCPAssPKVAyHPyPEDyGDIEIGsHRssssNLGADDG |
| Q9Y4H2 | Y803 | Sugiyama | IRS2 | FFsAALHPGGEPLRGVPGCCyssLPRSYKAPytCGGDsDQy |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y5Y0 | Y22 | Sugiyama | FLVCR1 FLVCR | ARPDDEEGAAVAPGHPLAKGyLPLPRGAPVGKESVELQNGP |
| Q9Y617 | Y101 | Sugiyama | PSAT1 PSA | GQFSAVPLNLIGLKAGRCADyVVTGAWSAKAAEEAKKFGTI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
| Q9Y6N7 | Y1114 | Sugiyama | ROBO1 DUTT1 | sGEKHWKPLGQQKQEVAPVQyNIVEQNKLNKDYRANDTVPP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.923217e-13 | 12.534 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.872103e-12 | 11.312 | 1 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.524151e-10 | 9.817 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.436643e-10 | 9.613 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.916716e-10 | 9.407 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.055779e-10 | 9.094 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.633179e-09 | 8.334 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.225200e-09 | 8.206 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 4.855647e-08 | 7.314 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.048401e-07 | 6.979 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 1.489000e-07 | 6.827 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.076891e-07 | 6.683 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.730029e-07 | 6.564 | 1 | 1 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.663741e-07 | 6.436 | 1 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.192766e-07 | 6.377 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.389757e-07 | 6.358 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.145059e-07 | 6.289 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.812830e-07 | 6.008 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.342518e-06 | 5.872 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.603276e-06 | 5.795 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.581572e-06 | 5.801 | 1 | 1 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.485696e-06 | 5.828 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.767572e-06 | 5.753 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.822332e-06 | 5.739 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.993050e-06 | 5.524 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.655757e-06 | 5.437 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.625675e-06 | 5.118 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.073674e-06 | 5.150 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.173215e-06 | 5.088 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.601099e-06 | 5.065 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.342039e-05 | 4.872 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.477216e-05 | 4.831 | 1 | 1 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.466006e-05 | 4.834 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.477216e-05 | 4.831 | 1 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.341169e-05 | 4.873 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.341169e-05 | 4.873 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.345597e-05 | 4.871 | 1 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.899822e-05 | 4.721 | 1 | 1 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.362068e-05 | 4.627 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.112202e-05 | 4.386 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.509401e-05 | 4.259 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.825896e-05 | 4.235 | 1 | 1 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.825896e-05 | 4.235 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.551061e-05 | 4.068 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.894488e-05 | 4.051 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.021486e-04 | 3.991 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.108117e-04 | 3.955 | 1 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.355594e-04 | 3.868 | 1 | 1 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.285885e-04 | 3.891 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.355594e-04 | 3.868 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.845013e-04 | 3.734 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.031137e-04 | 3.692 | 1 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.130573e-04 | 3.672 | 1 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.223353e-04 | 3.653 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.601338e-04 | 3.585 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.656603e-04 | 3.576 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.656603e-04 | 3.576 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.910436e-04 | 3.536 | 1 | 1 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.253747e-04 | 3.488 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.253747e-04 | 3.488 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.305667e-04 | 3.481 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.737921e-04 | 3.427 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.737921e-04 | 3.427 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.600949e-04 | 3.444 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.959415e-04 | 3.402 | 1 | 1 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.959415e-04 | 3.402 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.959415e-04 | 3.402 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.209142e-04 | 3.376 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.721293e-04 | 3.326 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.906693e-04 | 3.309 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.876298e-04 | 3.231 | 1 | 1 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.876298e-04 | 3.231 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.876298e-04 | 3.231 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.988031e-04 | 3.223 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.210699e-04 | 3.142 | 1 | 1 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.523140e-04 | 3.186 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.523140e-04 | 3.186 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.210699e-04 | 3.142 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.477120e-04 | 3.072 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.692314e-04 | 3.061 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.765105e-04 | 3.057 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.765105e-04 | 3.057 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 8.822569e-04 | 3.054 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.010775e-03 | 2.995 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.007171e-03 | 2.997 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.072031e-03 | 2.970 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.179532e-03 | 2.928 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.179532e-03 | 2.928 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.362761e-03 | 2.866 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.368895e-03 | 2.864 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.567966e-03 | 2.805 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.957447e-03 | 2.708 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.028143e-03 | 2.693 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.028143e-03 | 2.693 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.011561e-03 | 2.696 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.028143e-03 | 2.693 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.208518e-03 | 2.656 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.286491e-03 | 2.641 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.564355e-03 | 2.591 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.645719e-03 | 2.577 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.039536e-03 | 2.517 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 3.431549e-03 | 2.465 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 3.431549e-03 | 2.465 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.449332e-03 | 2.462 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.519734e-03 | 2.453 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.880244e-03 | 2.411 | 1 | 1 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.880244e-03 | 2.411 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.262456e-03 | 2.370 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.666744e-03 | 2.331 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.312812e-03 | 2.365 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.262456e-03 | 2.370 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.625575e-03 | 2.335 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.666744e-03 | 2.331 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.176909e-03 | 2.286 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.176909e-03 | 2.286 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.287414e-03 | 2.277 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.287414e-03 | 2.277 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.542957e-03 | 2.256 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.015537e-03 | 2.221 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.142217e-03 | 2.212 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.380595e-03 | 2.195 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.385481e-03 | 2.195 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.385481e-03 | 2.195 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.385481e-03 | 2.195 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.385481e-03 | 2.195 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.385481e-03 | 2.195 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.511507e-03 | 2.186 | 1 | 1 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.031151e-03 | 2.153 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.054420e-03 | 2.152 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.179601e-03 | 2.144 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.179601e-03 | 2.144 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.179601e-03 | 2.144 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.508431e-03 | 2.124 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.574733e-03 | 2.121 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.011725e-02 | 1.995 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.234005e-03 | 2.084 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.750825e-03 | 2.058 | 1 | 1 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.062473e-02 | 1.974 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.062473e-02 | 1.974 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.062473e-02 | 1.974 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.062473e-02 | 1.974 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.062473e-02 | 1.974 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.062473e-02 | 1.974 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.065989e-02 | 1.972 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.109331e-02 | 1.955 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.135178e-02 | 1.945 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 1.148957e-02 | 1.940 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.185248e-02 | 1.926 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.185904e-02 | 1.926 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.204754e-02 | 1.919 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.254378e-02 | 1.902 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.292231e-02 | 1.889 | 1 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.298209e-02 | 1.887 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.298209e-02 | 1.887 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.298209e-02 | 1.887 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.298209e-02 | 1.887 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.305291e-02 | 1.884 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.358014e-02 | 1.867 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.455421e-02 | 1.837 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.455421e-02 | 1.837 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.455421e-02 | 1.837 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.522055e-02 | 1.818 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 1.620408e-02 | 1.790 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.620408e-02 | 1.790 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.792990e-02 | 1.746 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.354538e-02 | 1.628 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.354538e-02 | 1.628 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.354538e-02 | 1.628 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.873414e-02 | 1.727 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.354538e-02 | 1.628 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.792990e-02 | 1.746 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.125341e-02 | 1.673 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.269268e-02 | 1.644 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.303325e-02 | 1.638 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 2.530452e-02 | 1.597 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.530452e-02 | 1.597 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.555746e-02 | 1.592 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.555746e-02 | 1.592 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.555746e-02 | 1.592 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.763688e-02 | 1.559 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.978199e-02 | 1.526 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.978199e-02 | 1.526 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.023985e-02 | 1.519 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.153865e-02 | 1.501 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.153865e-02 | 1.501 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.153865e-02 | 1.501 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.186732e-02 | 1.497 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.199117e-02 | 1.495 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.199117e-02 | 1.495 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.290740e-02 | 1.483 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.426284e-02 | 1.465 | 1 | 1 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.426284e-02 | 1.465 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.442127e-02 | 1.463 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.570582e-02 | 1.447 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.659544e-02 | 1.437 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.659544e-02 | 1.437 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.720902e-02 | 1.429 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.898743e-02 | 1.409 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.983736e-02 | 1.400 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.066984e-02 | 1.391 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.183019e-02 | 1.379 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.183019e-02 | 1.379 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.183019e-02 | 1.379 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.183019e-02 | 1.379 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.183019e-02 | 1.379 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.201300e-02 | 1.284 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.201300e-02 | 1.284 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.201300e-02 | 1.284 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 6.208821e-02 | 1.207 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.650481e-02 | 1.333 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 6.208821e-02 | 1.207 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.187679e-02 | 1.285 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.178635e-02 | 1.286 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.450388e-02 | 1.264 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.911953e-02 | 1.309 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 6.008561e-02 | 1.221 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.208821e-02 | 1.207 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.019265e-02 | 1.220 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.576110e-02 | 1.254 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.451048e-02 | 1.264 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.171615e-02 | 1.286 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.426149e-02 | 1.266 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.392724e-02 | 1.357 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.392724e-02 | 1.357 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.679506e-02 | 1.246 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.891044e-02 | 1.230 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.848210e-02 | 1.233 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.323599e-02 | 1.364 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.294716e-02 | 1.201 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.546354e-02 | 1.184 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 6.557384e-02 | 1.183 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.585409e-02 | 1.181 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.585409e-02 | 1.181 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.585409e-02 | 1.181 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.880514e-02 | 1.162 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.027460e-02 | 1.153 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.179904e-02 | 1.144 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.205696e-02 | 1.142 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.205696e-02 | 1.142 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.205696e-02 | 1.142 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 7.205696e-02 | 1.142 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 7.205696e-02 | 1.142 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 7.205696e-02 | 1.142 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.205696e-02 | 1.142 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.205696e-02 | 1.142 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.205696e-02 | 1.142 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.205696e-02 | 1.142 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.616440e-02 | 1.118 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.713341e-02 | 1.113 | 1 | 1 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.791051e-02 | 1.108 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.791051e-02 | 1.108 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.791051e-02 | 1.108 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.791051e-02 | 1.108 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 8.192037e-02 | 1.087 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 8.192037e-02 | 1.087 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 8.192037e-02 | 1.087 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 8.192037e-02 | 1.087 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 9.167954e-02 | 1.038 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.167954e-02 | 1.038 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.013356e-01 | 0.994 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.013356e-01 | 0.994 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 1.013356e-01 | 0.994 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.108895e-01 | 0.955 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.108895e-01 | 0.955 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 1.108895e-01 | 0.955 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.108895e-01 | 0.955 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.108895e-01 | 0.955 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.108895e-01 | 0.955 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.203425e-01 | 0.920 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.203425e-01 | 0.920 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.203425e-01 | 0.920 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.203425e-01 | 0.920 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.296956e-01 | 0.887 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.296956e-01 | 0.887 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 1.296956e-01 | 0.887 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 1.389497e-01 | 0.857 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.389497e-01 | 0.857 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.389497e-01 | 0.857 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.389497e-01 | 0.857 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.481061e-01 | 0.829 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.481061e-01 | 0.829 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.571656e-01 | 0.804 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.571656e-01 | 0.804 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.571656e-01 | 0.804 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.571656e-01 | 0.804 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.571656e-01 | 0.804 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.571656e-01 | 0.804 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.425669e-01 | 0.846 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.499062e-01 | 0.824 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.013356e-01 | 0.994 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.405332e-01 | 0.852 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 8.192037e-02 | 1.087 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.571656e-01 | 0.804 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.415091e-01 | 0.849 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.004764e-01 | 0.998 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.203425e-01 | 0.920 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.517573e-02 | 1.021 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.479484e-01 | 0.830 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.481061e-01 | 0.829 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.192037e-02 | 1.087 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.108895e-01 | 0.955 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.108895e-01 | 0.955 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.389497e-01 | 0.857 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.389497e-01 | 0.857 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.389497e-01 | 0.857 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.481061e-01 | 0.829 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.481061e-01 | 0.829 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.481061e-01 | 0.829 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.481061e-01 | 0.829 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.038732e-02 | 1.044 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.429907e-01 | 0.845 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.353084e-01 | 0.869 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.571656e-01 | 0.804 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.108895e-01 | 0.955 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.108895e-01 | 0.955 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.013356e-01 | 0.994 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.571656e-01 | 0.804 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.571656e-01 | 0.804 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.038345e-01 | 0.984 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.106410e-01 | 0.956 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.013356e-01 | 0.994 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.203425e-01 | 0.920 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.296956e-01 | 0.887 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.208366e-01 | 0.918 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.571656e-01 | 0.804 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.571656e-01 | 0.804 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.191023e-01 | 0.924 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.385555e-02 | 1.028 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.214195e-01 | 0.916 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 9.167954e-02 | 1.038 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.108895e-01 | 0.955 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.108895e-01 | 0.955 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.203425e-01 | 0.920 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.571656e-01 | 0.804 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.571656e-01 | 0.804 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.462269e-01 | 0.835 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.536040e-01 | 0.814 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.044475e-01 | 0.981 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.448129e-02 | 1.073 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.192037e-02 | 1.087 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.385555e-02 | 1.028 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.100043e-01 | 0.959 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.506691e-02 | 1.070 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.332421e-02 | 1.079 | 1 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.462269e-01 | 0.835 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.472352e-01 | 0.832 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.499062e-01 | 0.824 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.555358e-02 | 1.068 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.296122e-01 | 0.887 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.106410e-01 | 0.956 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.106410e-01 | 0.956 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.389497e-01 | 0.857 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.203425e-01 | 0.920 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.267405e-02 | 1.083 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.353084e-01 | 0.869 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.536040e-01 | 0.814 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.510991e-01 | 0.821 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.510991e-01 | 0.821 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.004764e-01 | 0.998 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.853317e-02 | 1.053 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.434470e-01 | 0.843 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.030975e-01 | 0.987 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.072231e-01 | 0.970 | 1 | 1 |
| G1 Phase | R-HSA-69236 | 1.072231e-01 | 0.970 | 1 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.499062e-01 | 0.824 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.140874e-01 | 0.943 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.573196e-01 | 0.803 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 1.605806e-01 | 0.794 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.605806e-01 | 0.794 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.605806e-01 | 0.794 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 1.648009e-01 | 0.783 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 1.648009e-01 | 0.783 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.661294e-01 | 0.780 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.661294e-01 | 0.780 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 1.661294e-01 | 0.780 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 1.661294e-01 | 0.780 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.685650e-01 | 0.773 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.685650e-01 | 0.773 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.709147e-01 | 0.767 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.713425e-01 | 0.766 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.723438e-01 | 0.764 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.749983e-01 | 0.757 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.749983e-01 | 0.757 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.749983e-01 | 0.757 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.749983e-01 | 0.757 | 1 | 1 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.761366e-01 | 0.754 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.761524e-01 | 0.754 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.782064e-01 | 0.749 | 1 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 1.799425e-01 | 0.745 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.837735e-01 | 0.736 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.837735e-01 | 0.736 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.837735e-01 | 0.736 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.837735e-01 | 0.736 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.837735e-01 | 0.736 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.837735e-01 | 0.736 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.837735e-01 | 0.736 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.837735e-01 | 0.736 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.837735e-01 | 0.736 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.837735e-01 | 0.736 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.840919e-01 | 0.735 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.875914e-01 | 0.727 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.914328e-01 | 0.718 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.924559e-01 | 0.716 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.924559e-01 | 0.716 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.924559e-01 | 0.716 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.924559e-01 | 0.716 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.924559e-01 | 0.716 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.962524e-01 | 0.707 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.010464e-01 | 0.697 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.010464e-01 | 0.697 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.010464e-01 | 0.697 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.010464e-01 | 0.697 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.010464e-01 | 0.697 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.010464e-01 | 0.697 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.030176e-01 | 0.692 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.068972e-01 | 0.684 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.095461e-01 | 0.679 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.095461e-01 | 0.679 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.107848e-01 | 0.676 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.143742e-01 | 0.669 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.179559e-01 | 0.662 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.179559e-01 | 0.662 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.179559e-01 | 0.662 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.179559e-01 | 0.662 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.179559e-01 | 0.662 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.179559e-01 | 0.662 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.250656e-01 | 0.648 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.262767e-01 | 0.645 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.262767e-01 | 0.645 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 2.262767e-01 | 0.645 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.342443e-01 | 0.630 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.345095e-01 | 0.630 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.345095e-01 | 0.630 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.345095e-01 | 0.630 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.345095e-01 | 0.630 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.345095e-01 | 0.630 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.345095e-01 | 0.630 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.381713e-01 | 0.623 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.421018e-01 | 0.616 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 2.426552e-01 | 0.615 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.426552e-01 | 0.615 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.426552e-01 | 0.615 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.426552e-01 | 0.615 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.426552e-01 | 0.615 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.507147e-01 | 0.601 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.507147e-01 | 0.601 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.507147e-01 | 0.601 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.507147e-01 | 0.601 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.507147e-01 | 0.601 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.507147e-01 | 0.601 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.507147e-01 | 0.601 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.538352e-01 | 0.595 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.561472e-01 | 0.592 | 1 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.586890e-01 | 0.587 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.586890e-01 | 0.587 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.586890e-01 | 0.587 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.586890e-01 | 0.587 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.617886e-01 | 0.582 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.617886e-01 | 0.582 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.657294e-01 | 0.576 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.657294e-01 | 0.576 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.665789e-01 | 0.574 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.665789e-01 | 0.574 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.665789e-01 | 0.574 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.692681e-01 | 0.570 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.693789e-01 | 0.570 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 2.696703e-01 | 0.569 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.704740e-01 | 0.568 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.743852e-01 | 0.562 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.743852e-01 | 0.562 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.762308e-01 | 0.559 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.791140e-01 | 0.554 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.821090e-01 | 0.550 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.821090e-01 | 0.550 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.854259e-01 | 0.545 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.897510e-01 | 0.538 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.897510e-01 | 0.538 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.897510e-01 | 0.538 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.897510e-01 | 0.538 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 2.897510e-01 | 0.538 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.942410e-01 | 0.531 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.973122e-01 | 0.527 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.973122e-01 | 0.527 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.973122e-01 | 0.527 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.973122e-01 | 0.527 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.973122e-01 | 0.527 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.047933e-01 | 0.516 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.047933e-01 | 0.516 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.050676e-01 | 0.516 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.050715e-01 | 0.516 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.121952e-01 | 0.506 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.121952e-01 | 0.506 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 3.121952e-01 | 0.506 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.121952e-01 | 0.506 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.168144e-01 | 0.499 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.195188e-01 | 0.496 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.195188e-01 | 0.496 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.195188e-01 | 0.496 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.195188e-01 | 0.496 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.217339e-01 | 0.493 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.267648e-01 | 0.486 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.267648e-01 | 0.486 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.267648e-01 | 0.486 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.267648e-01 | 0.486 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.285123e-01 | 0.483 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.324001e-01 | 0.478 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 3.339342e-01 | 0.476 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.339342e-01 | 0.476 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.339342e-01 | 0.476 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.401564e-01 | 0.468 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.410276e-01 | 0.467 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.410276e-01 | 0.467 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.410276e-01 | 0.467 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.478851e-01 | 0.459 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.480459e-01 | 0.458 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.480459e-01 | 0.458 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.480459e-01 | 0.458 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 3.480459e-01 | 0.458 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.549899e-01 | 0.450 | 1 | 1 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.549899e-01 | 0.450 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.549899e-01 | 0.450 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.579137e-01 | 0.446 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.594214e-01 | 0.444 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.618603e-01 | 0.441 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.618603e-01 | 0.441 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.618603e-01 | 0.441 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.670714e-01 | 0.435 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.670714e-01 | 0.435 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.686580e-01 | 0.433 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.686580e-01 | 0.433 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.686580e-01 | 0.433 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.686580e-01 | 0.433 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.753837e-01 | 0.426 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.753837e-01 | 0.426 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.820382e-01 | 0.418 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.886222e-01 | 0.410 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.886222e-01 | 0.410 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.886222e-01 | 0.410 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.949702e-01 | 0.403 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.951364e-01 | 0.403 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.951364e-01 | 0.403 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.951364e-01 | 0.403 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.951364e-01 | 0.403 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 3.951364e-01 | 0.403 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.015816e-01 | 0.396 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.015816e-01 | 0.396 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.047567e-01 | 0.393 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.047567e-01 | 0.393 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.079586e-01 | 0.389 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 4.079586e-01 | 0.389 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.079586e-01 | 0.389 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.084683e-01 | 0.389 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.142679e-01 | 0.383 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.142679e-01 | 0.383 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.195354e-01 | 0.377 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.232013e-01 | 0.373 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.232013e-01 | 0.373 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.266868e-01 | 0.370 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.266868e-01 | 0.370 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.304973e-01 | 0.366 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.311798e-01 | 0.365 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.327978e-01 | 0.364 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.327978e-01 | 0.364 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 4.327978e-01 | 0.364 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.388439e-01 | 0.358 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.388439e-01 | 0.358 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.388439e-01 | 0.358 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.413497e-01 | 0.355 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.413497e-01 | 0.355 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.413497e-01 | 0.355 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.448260e-01 | 0.352 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.507447e-01 | 0.346 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.566006e-01 | 0.340 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 4.566006e-01 | 0.340 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.623945e-01 | 0.335 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.623945e-01 | 0.335 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.624855e-01 | 0.335 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.652331e-01 | 0.332 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.681270e-01 | 0.330 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.681270e-01 | 0.330 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.681270e-01 | 0.330 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.737986e-01 | 0.324 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.737986e-01 | 0.324 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.777700e-01 | 0.321 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 4.828726e-01 | 0.316 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.904373e-01 | 0.309 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 4.904554e-01 | 0.309 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.923611e-01 | 0.308 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.929085e-01 | 0.307 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.958903e-01 | 0.305 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.012676e-01 | 0.300 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.118517e-01 | 0.291 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.118517e-01 | 0.291 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.118517e-01 | 0.291 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.118517e-01 | 0.291 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.118517e-01 | 0.291 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 5.170597e-01 | 0.286 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 5.170597e-01 | 0.286 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.172566e-01 | 0.286 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.273105e-01 | 0.278 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.273105e-01 | 0.278 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.273105e-01 | 0.278 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.323545e-01 | 0.274 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.335402e-01 | 0.273 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 5.398517e-01 | 0.268 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.422826e-01 | 0.266 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.494473e-01 | 0.260 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.494473e-01 | 0.260 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.520010e-01 | 0.258 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.520010e-01 | 0.258 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.567830e-01 | 0.254 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.567830e-01 | 0.254 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.644730e-01 | 0.248 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.661954e-01 | 0.247 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.671134e-01 | 0.246 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.708267e-01 | 0.243 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.708267e-01 | 0.243 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.708267e-01 | 0.243 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.741035e-01 | 0.241 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.754089e-01 | 0.240 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.754089e-01 | 0.240 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.799425e-01 | 0.237 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.801133e-01 | 0.236 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.844280e-01 | 0.233 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.888658e-01 | 0.230 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.888658e-01 | 0.230 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.006591e-01 | 0.221 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.018985e-01 | 0.220 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.018985e-01 | 0.220 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.061508e-01 | 0.217 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.063895e-01 | 0.217 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.092315e-01 | 0.215 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.092315e-01 | 0.215 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.092315e-01 | 0.215 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.103580e-01 | 0.214 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.103580e-01 | 0.214 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.145204e-01 | 0.211 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.145204e-01 | 0.211 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.148688e-01 | 0.211 | 1 | 1 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.186387e-01 | 0.209 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.188605e-01 | 0.208 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.211189e-01 | 0.207 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.227132e-01 | 0.206 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 6.232086e-01 | 0.205 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.267444e-01 | 0.203 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.267444e-01 | 0.203 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.307328e-01 | 0.200 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.346789e-01 | 0.197 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.385830e-01 | 0.195 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.424456e-01 | 0.192 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 6.447685e-01 | 0.191 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.462672e-01 | 0.190 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 6.494533e-01 | 0.187 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.500050e-01 | 0.187 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.551803e-01 | 0.184 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.574900e-01 | 0.182 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.653488e-01 | 0.177 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.703425e-01 | 0.174 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.703425e-01 | 0.174 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.754133e-01 | 0.170 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.788845e-01 | 0.168 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.801499e-01 | 0.167 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.823187e-01 | 0.166 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.823187e-01 | 0.166 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 6.825645e-01 | 0.166 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.890780e-01 | 0.162 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.920751e-01 | 0.160 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.924039e-01 | 0.160 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.924039e-01 | 0.160 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.944160e-01 | 0.158 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.021707e-01 | 0.154 | 0 | 0 |
| Translation | R-HSA-72766 | 7.106366e-01 | 0.148 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.116292e-01 | 0.148 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 7.116292e-01 | 0.148 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.116292e-01 | 0.148 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.116292e-01 | 0.148 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.177683e-01 | 0.144 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.235347e-01 | 0.141 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.237775e-01 | 0.140 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.382496e-01 | 0.132 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.410523e-01 | 0.130 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.443197e-01 | 0.128 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.522541e-01 | 0.124 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.546243e-01 | 0.122 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.572527e-01 | 0.121 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.649708e-01 | 0.116 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.772960e-01 | 0.109 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.853946e-01 | 0.105 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.871170e-01 | 0.104 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.912407e-01 | 0.102 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.934789e-01 | 0.100 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.956933e-01 | 0.099 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.978840e-01 | 0.098 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.988387e-01 | 0.098 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.064158e-01 | 0.093 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 8.084922e-01 | 0.092 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.165787e-01 | 0.088 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.173420e-01 | 0.088 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.204938e-01 | 0.086 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.299216e-01 | 0.081 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.317473e-01 | 0.080 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.348149e-01 | 0.078 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.353403e-01 | 0.078 | 1 | 1 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.388571e-01 | 0.076 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.388571e-01 | 0.076 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.405873e-01 | 0.075 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.439927e-01 | 0.074 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.455691e-01 | 0.073 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.456681e-01 | 0.073 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.473256e-01 | 0.072 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.473256e-01 | 0.072 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.505878e-01 | 0.070 | 1 | 1 |
| Phospholipid metabolism | R-HSA-1483257 | 8.517932e-01 | 0.070 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.521928e-01 | 0.069 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.629580e-01 | 0.064 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.687557e-01 | 0.061 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.714198e-01 | 0.060 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.756610e-01 | 0.058 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.831066e-01 | 0.054 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.850676e-01 | 0.053 | 1 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.871928e-01 | 0.052 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.896073e-01 | 0.051 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.919705e-01 | 0.050 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.931331e-01 | 0.049 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 8.937961e-01 | 0.049 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.066183e-01 | 0.043 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.184802e-01 | 0.037 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.227809e-01 | 0.035 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.287336e-01 | 0.032 | 1 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.313698e-01 | 0.031 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.350839e-01 | 0.029 | 1 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.385130e-01 | 0.028 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.436289e-01 | 0.025 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.445053e-01 | 0.025 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.448403e-01 | 0.025 | 1 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.474841e-01 | 0.023 | 1 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.537791e-01 | 0.021 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.673582e-01 | 0.014 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.686124e-01 | 0.014 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.756241e-01 | 0.011 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.835516e-01 | 0.007 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.891515e-01 | 0.005 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.902786e-01 | 0.004 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.906421e-01 | 0.004 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.949068e-01 | 0.002 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.972906e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.979834e-01 | 0.001 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.991466e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.998983e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.000000e+00 | 0.000 | 1 | 1 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.000000e+00 | 0.000 | 1 | 1 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.000000e+00 | 0.000 | 1 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.000000e+00 | 0.000 | 1 | 1 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.000000e+00 | 0.000 | 1 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.000000e+00 | 0.000 | 1 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.000000e+00 | 0.000 | 1 | 1 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.000000e+00 | 0.000 | 1 | 1 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.000000e+00 | 0.000 | 1 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-20 family signaling | R-HSA-8854691 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.000000e+00 | 0.000 | 1 | 1 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 2.109424e-15 | 14.676 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.265654e-14 | 13.898 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.802026e-13 | 12.236 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.458212e-12 | 11.351 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.303824e-12 | 11.136 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.140643e-11 | 10.503 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.872635e-11 | 10.542 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.378975e-11 | 10.471 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.528689e-11 | 10.344 | 1 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.396593e-10 | 9.855 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.216200e-09 | 8.915 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.096872e-09 | 8.678 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.096872e-09 | 8.678 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.019466e-09 | 8.695 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.821549e-09 | 8.550 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.846587e-09 | 8.415 | 1 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.849107e-09 | 8.415 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.780384e-09 | 8.321 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.225200e-09 | 8.206 | 1 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.980645e-09 | 8.156 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.058699e-09 | 8.094 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.627488e-09 | 8.016 | 1 | 1 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.627488e-09 | 8.016 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.627488e-09 | 8.016 | 1 | 1 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.627488e-09 | 8.016 | 1 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.131308e-08 | 7.946 | 1 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.773503e-08 | 7.751 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.981492e-08 | 7.703 | 1 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.130763e-08 | 7.671 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.539454e-08 | 7.595 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.822347e-08 | 7.549 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.061358e-08 | 7.514 | 1 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.923225e-08 | 7.406 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.621384e-08 | 7.335 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.634066e-08 | 7.178 | 1 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.601669e-08 | 7.119 | 1 | 1 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.513025e-08 | 7.124 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.604116e-08 | 7.065 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.048401e-07 | 6.979 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.128522e-07 | 6.947 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.221504e-07 | 6.913 | 1 | 1 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.240374e-07 | 6.906 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.414290e-07 | 6.849 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.707964e-07 | 6.768 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.766919e-07 | 6.753 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.793152e-07 | 6.746 | 1 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.085127e-07 | 6.681 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.033294e-07 | 6.692 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.028210e-07 | 6.693 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.395759e-07 | 6.469 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.909524e-07 | 6.408 | 1 | 1 |
| M Phase | R-HSA-68886 | 4.062783e-07 | 6.391 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.091316e-07 | 6.388 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.557291e-07 | 6.341 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.934470e-07 | 6.307 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.207393e-07 | 6.283 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.623617e-07 | 6.250 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.892205e-07 | 6.230 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.989655e-07 | 6.223 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.004971e-07 | 6.046 | 1 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.166153e-06 | 5.933 | 1 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.216806e-06 | 5.915 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.485696e-06 | 5.828 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.494041e-06 | 5.826 | 1 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.589042e-06 | 5.587 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.011790e-06 | 5.521 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.993050e-06 | 5.524 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.176376e-06 | 5.498 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.496962e-06 | 5.456 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.791888e-06 | 5.421 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.668133e-06 | 5.436 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.791888e-06 | 5.421 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.956324e-06 | 5.403 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.626483e-06 | 5.250 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.767183e-06 | 5.239 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.767183e-06 | 5.239 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.788219e-06 | 5.237 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.250517e-06 | 5.204 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.902626e-06 | 5.161 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.994970e-06 | 5.155 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.968081e-06 | 5.099 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.410523e-06 | 5.075 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.601099e-06 | 5.065 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.412995e-06 | 5.075 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.412995e-06 | 5.075 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.018217e-05 | 4.992 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.163299e-05 | 4.934 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.341169e-05 | 4.873 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.341169e-05 | 4.873 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.345202e-05 | 4.871 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.342039e-05 | 4.872 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.345597e-05 | 4.871 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.662619e-05 | 4.779 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.697776e-05 | 4.770 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.744607e-05 | 4.758 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.907435e-05 | 4.720 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.050205e-05 | 4.688 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.121530e-05 | 4.673 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.362068e-05 | 4.627 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.256033e-05 | 4.647 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.367193e-05 | 4.626 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.819546e-05 | 4.550 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.910829e-05 | 4.536 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.217898e-05 | 4.492 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.562658e-05 | 4.448 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.703985e-05 | 4.431 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.921754e-05 | 4.407 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.970775e-05 | 4.401 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.015118e-05 | 4.396 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.068535e-05 | 4.391 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.245098e-05 | 4.372 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.845446e-05 | 4.315 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.845446e-05 | 4.315 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.003112e-05 | 4.301 | 1 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.509401e-05 | 4.259 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.616501e-05 | 4.251 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.616501e-05 | 4.251 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.616501e-05 | 4.251 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.688369e-05 | 4.245 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.825896e-05 | 4.235 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.825896e-05 | 4.235 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.869412e-05 | 4.231 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.538951e-05 | 4.069 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.551061e-05 | 4.068 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.551061e-05 | 4.068 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.648172e-05 | 4.016 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.021486e-04 | 3.991 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.089992e-04 | 3.963 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.089992e-04 | 3.963 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.990622e-05 | 4.000 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.106524e-04 | 3.956 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.210189e-04 | 3.917 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.310976e-04 | 3.882 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.488944e-04 | 3.827 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.638240e-04 | 3.786 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.842359e-04 | 3.735 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.845013e-04 | 3.734 | 1 | 1 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.032053e-04 | 3.692 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.221199e-04 | 3.653 | 1 | 1 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.224272e-04 | 3.653 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.436556e-04 | 3.613 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.544894e-04 | 3.594 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.250970e-04 | 3.648 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.264714e-04 | 3.645 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.287354e-04 | 3.641 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.292911e-04 | 3.640 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.630837e-04 | 3.580 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.793376e-04 | 3.554 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.793376e-04 | 3.554 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.910436e-04 | 3.536 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.305667e-04 | 3.481 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.335119e-04 | 3.477 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.419623e-04 | 3.466 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.419623e-04 | 3.466 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.592212e-04 | 3.445 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.737921e-04 | 3.427 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.959415e-04 | 3.402 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.049508e-04 | 3.393 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.463638e-04 | 3.350 | 1 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.721293e-04 | 3.326 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.934069e-04 | 3.307 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.988031e-04 | 3.223 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.876298e-04 | 3.231 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.481297e-04 | 3.261 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.481297e-04 | 3.261 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.988031e-04 | 3.223 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.276349e-04 | 3.278 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.876298e-04 | 3.231 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.877338e-04 | 3.231 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.523140e-04 | 3.186 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.715355e-04 | 3.173 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.342139e-04 | 3.079 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.581695e-04 | 3.066 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.581695e-04 | 3.066 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.692314e-04 | 3.061 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.765105e-04 | 3.057 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.765105e-04 | 3.057 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.010775e-03 | 2.995 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.010775e-03 | 2.995 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.053112e-03 | 2.978 | 1 | 1 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.053112e-03 | 2.978 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.053112e-03 | 2.978 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.059922e-03 | 2.975 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.072031e-03 | 2.970 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.072031e-03 | 2.970 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.072031e-03 | 2.970 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.139940e-03 | 2.943 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.150160e-03 | 2.939 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.172676e-03 | 2.931 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.179532e-03 | 2.928 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.179532e-03 | 2.928 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 1.179532e-03 | 2.928 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.179532e-03 | 2.928 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.253309e-03 | 2.902 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.256927e-03 | 2.901 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.567966e-03 | 2.805 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.365064e-03 | 2.865 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.335014e-03 | 2.875 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.594582e-03 | 2.797 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.730935e-03 | 2.762 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.730935e-03 | 2.762 | 1 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.788809e-03 | 2.747 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.799398e-03 | 2.745 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.803555e-03 | 2.744 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.863131e-03 | 2.730 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.869293e-03 | 2.728 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.957447e-03 | 2.708 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.957447e-03 | 2.708 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.006192e-03 | 2.698 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.011561e-03 | 2.696 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.286491e-03 | 2.641 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.286491e-03 | 2.641 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.322170e-03 | 2.634 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.322170e-03 | 2.634 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.456045e-03 | 2.610 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.564355e-03 | 2.591 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.564355e-03 | 2.591 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.590367e-03 | 2.587 | 1 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.645719e-03 | 2.577 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.664317e-03 | 2.574 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.708683e-03 | 2.567 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.862216e-03 | 2.543 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.862216e-03 | 2.543 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.862773e-03 | 2.543 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.039536e-03 | 2.517 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.180530e-03 | 2.498 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.240019e-03 | 2.489 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.431549e-03 | 2.465 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.312812e-03 | 2.365 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.519734e-03 | 2.453 | 1 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.519734e-03 | 2.453 | 1 | 1 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.880244e-03 | 2.411 | 1 | 1 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.519734e-03 | 2.453 | 1 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.918560e-03 | 2.407 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.509014e-03 | 2.455 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.726373e-03 | 2.429 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.312812e-03 | 2.365 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.312812e-03 | 2.365 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.822734e-03 | 2.418 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.636921e-03 | 2.334 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.646003e-03 | 2.333 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.841902e-03 | 2.315 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.900767e-03 | 2.310 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.961061e-03 | 2.304 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.966489e-03 | 2.304 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.043598e-03 | 2.297 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.093465e-03 | 2.293 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.176909e-03 | 2.286 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.287414e-03 | 2.277 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.287414e-03 | 2.277 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.287414e-03 | 2.277 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.684382e-03 | 2.245 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.684382e-03 | 2.245 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.727544e-03 | 2.242 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.910175e-03 | 2.228 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.910175e-03 | 2.228 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.015537e-03 | 2.221 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.047269e-03 | 2.218 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.353295e-03 | 2.197 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.353295e-03 | 2.197 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.353295e-03 | 2.197 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.353295e-03 | 2.197 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.353295e-03 | 2.197 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.385481e-03 | 2.195 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.511507e-03 | 2.186 | 1 | 1 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.562259e-03 | 2.183 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.508431e-03 | 2.124 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.508431e-03 | 2.124 | 1 | 1 |
| Downstream signal transduction | R-HSA-186763 | 7.574733e-03 | 2.121 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.948834e-03 | 2.100 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.374656e-03 | 2.077 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.054420e-03 | 2.152 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.763574e-03 | 2.170 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.750825e-03 | 2.058 | 1 | 1 |
| DAP12 signaling | R-HSA-2424491 | 7.031151e-03 | 2.153 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.734695e-03 | 2.059 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.977735e-03 | 2.098 | 1 | 1 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.508431e-03 | 2.124 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.574733e-03 | 2.121 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.142503e-03 | 2.089 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.399230e-03 | 2.131 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.750825e-03 | 2.058 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.054420e-03 | 2.152 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.508431e-03 | 2.124 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.763574e-03 | 2.170 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.750825e-03 | 2.058 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.553404e-03 | 2.068 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.750825e-03 | 2.058 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.825508e-03 | 2.054 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.283489e-03 | 2.032 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.445774e-03 | 2.025 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.445774e-03 | 2.025 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.445774e-03 | 2.025 | 0 | 0 |
| Translation | R-HSA-72766 | 9.453212e-03 | 2.024 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.805080e-03 | 2.009 | 1 | 1 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.993193e-03 | 2.000 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.993193e-03 | 2.000 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.007851e-02 | 1.997 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.007851e-02 | 1.997 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.007851e-02 | 1.997 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.034725e-02 | 1.985 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.043152e-02 | 1.982 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.043152e-02 | 1.982 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.062473e-02 | 1.974 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.062473e-02 | 1.974 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.062473e-02 | 1.974 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.062473e-02 | 1.974 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.062473e-02 | 1.974 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.062473e-02 | 1.974 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.062473e-02 | 1.974 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.062473e-02 | 1.974 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.062473e-02 | 1.974 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.062473e-02 | 1.974 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.062473e-02 | 1.974 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.062473e-02 | 1.974 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.062473e-02 | 1.974 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.062473e-02 | 1.974 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.062473e-02 | 1.974 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.062473e-02 | 1.974 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.062473e-02 | 1.974 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.062473e-02 | 1.974 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.062473e-02 | 1.974 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.062473e-02 | 1.974 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.062473e-02 | 1.974 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.062473e-02 | 1.974 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.063508e-02 | 1.973 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.065989e-02 | 1.972 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.065989e-02 | 1.972 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.082254e-02 | 1.966 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.109331e-02 | 1.955 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.112651e-02 | 1.954 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.112651e-02 | 1.954 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.112651e-02 | 1.954 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.119998e-02 | 1.951 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.135178e-02 | 1.945 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.135178e-02 | 1.945 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.148957e-02 | 1.940 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.148957e-02 | 1.940 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.148957e-02 | 1.940 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.148957e-02 | 1.940 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.206903e-02 | 1.918 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.210133e-02 | 1.917 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.281177e-02 | 1.892 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.298209e-02 | 1.887 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.298209e-02 | 1.887 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.298209e-02 | 1.887 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.298209e-02 | 1.887 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.298209e-02 | 1.887 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.298209e-02 | 1.887 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.358014e-02 | 1.867 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.374220e-02 | 1.862 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.437426e-02 | 1.842 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.792990e-02 | 1.746 | 1 | 1 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.792990e-02 | 1.746 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.792990e-02 | 1.746 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.972988e-02 | 1.705 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.519422e-02 | 1.818 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.160228e-02 | 1.666 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.160228e-02 | 1.666 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.519422e-02 | 1.818 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.792990e-02 | 1.746 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.781001e-02 | 1.749 | 1 | 1 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.160228e-02 | 1.666 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.160228e-02 | 1.666 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.066095e-02 | 1.685 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.568414e-02 | 1.805 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.522055e-02 | 1.818 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.620408e-02 | 1.790 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.792990e-02 | 1.746 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.620408e-02 | 1.790 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.873414e-02 | 1.727 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.160228e-02 | 1.666 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.968444e-02 | 1.706 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.968444e-02 | 1.706 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.935522e-02 | 1.713 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.620408e-02 | 1.790 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.455421e-02 | 1.837 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.968444e-02 | 1.706 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.464592e-02 | 1.834 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.860431e-02 | 1.730 | 1 | 1 |
| Response to metal ions | R-HSA-5660526 | 2.160228e-02 | 1.666 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.354538e-02 | 1.628 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.354538e-02 | 1.628 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.374791e-02 | 1.624 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.555746e-02 | 1.592 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.555746e-02 | 1.592 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.593704e-02 | 1.586 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.707090e-02 | 1.567 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.707090e-02 | 1.567 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.763688e-02 | 1.559 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.853614e-02 | 1.545 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.853614e-02 | 1.545 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.938064e-02 | 1.532 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.978199e-02 | 1.526 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.978199e-02 | 1.526 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.023985e-02 | 1.519 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.153865e-02 | 1.501 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.153865e-02 | 1.501 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.153865e-02 | 1.501 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.186732e-02 | 1.497 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.186732e-02 | 1.497 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.186732e-02 | 1.497 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.199117e-02 | 1.495 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.199117e-02 | 1.495 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.199117e-02 | 1.495 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.199117e-02 | 1.495 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.290740e-02 | 1.483 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.295726e-02 | 1.482 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.368731e-02 | 1.473 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.426284e-02 | 1.465 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.426284e-02 | 1.465 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.426284e-02 | 1.465 | 1 | 1 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.426284e-02 | 1.465 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.570582e-02 | 1.447 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.659544e-02 | 1.437 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.659544e-02 | 1.437 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.827880e-02 | 1.417 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.844506e-02 | 1.415 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.844506e-02 | 1.415 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.844506e-02 | 1.415 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.898743e-02 | 1.409 | 1 | 1 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.898743e-02 | 1.409 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.066984e-02 | 1.391 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.125499e-02 | 1.385 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.143731e-02 | 1.383 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.183019e-02 | 1.379 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.183019e-02 | 1.379 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.183019e-02 | 1.379 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.183019e-02 | 1.379 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.183019e-02 | 1.379 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.183019e-02 | 1.379 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.183019e-02 | 1.379 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.183019e-02 | 1.379 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.183019e-02 | 1.379 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.269783e-02 | 1.370 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.275989e-02 | 1.369 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.323599e-02 | 1.364 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.394359e-02 | 1.357 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.394359e-02 | 1.357 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.416576e-02 | 1.355 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.416576e-02 | 1.355 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.674595e-02 | 1.330 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.711897e-02 | 1.327 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.871868e-02 | 1.312 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.911953e-02 | 1.309 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.911953e-02 | 1.309 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 5.054459e-02 | 1.296 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.201300e-02 | 1.284 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.201300e-02 | 1.284 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.201300e-02 | 1.284 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.208821e-02 | 1.207 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.208821e-02 | 1.207 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.205696e-02 | 1.142 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.205696e-02 | 1.142 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.205696e-02 | 1.142 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 8.192037e-02 | 1.087 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.192037e-02 | 1.087 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 8.192037e-02 | 1.087 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 9.167954e-02 | 1.038 | 1 | 1 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.013356e-01 | 0.994 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.013356e-01 | 0.994 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.013356e-01 | 0.994 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.013356e-01 | 0.994 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.013356e-01 | 0.994 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.450388e-02 | 1.264 | 1 | 1 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.450388e-02 | 1.264 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.008561e-02 | 1.221 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.880514e-02 | 1.162 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.903424e-02 | 1.004 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.013356e-01 | 0.994 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.880514e-02 | 1.162 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.059497e-02 | 1.043 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.008561e-02 | 1.221 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 7.205696e-02 | 1.142 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.013356e-01 | 0.994 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.483457e-02 | 1.126 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.483457e-02 | 1.126 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.714972e-02 | 1.013 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.004764e-01 | 0.998 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.192653e-02 | 1.208 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.192037e-02 | 1.087 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.417891e-02 | 1.075 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.102569e-02 | 1.091 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.004764e-01 | 0.998 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.201300e-02 | 1.284 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.201300e-02 | 1.284 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 8.192037e-02 | 1.087 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.013356e-01 | 0.994 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.013356e-01 | 0.994 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.791051e-02 | 1.108 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.102569e-02 | 1.091 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.102569e-02 | 1.091 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.714972e-02 | 1.013 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.200032e-02 | 1.086 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.909158e-02 | 1.161 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 6.557384e-02 | 1.183 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.050562e-02 | 1.094 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.450388e-02 | 1.264 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.585409e-02 | 1.181 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.736905e-02 | 1.059 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.880514e-02 | 1.162 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.179904e-02 | 1.144 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.179904e-02 | 1.144 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.483457e-02 | 1.126 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.714972e-02 | 1.013 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.714972e-02 | 1.013 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.102569e-02 | 1.091 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.178635e-02 | 1.286 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.791051e-02 | 1.108 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.059497e-02 | 1.043 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.385555e-02 | 1.028 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.443535e-02 | 1.073 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.187679e-02 | 1.285 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.727074e-02 | 1.242 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.417891e-02 | 1.075 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.201300e-02 | 1.284 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.102569e-02 | 1.091 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.736905e-02 | 1.059 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.594190e-02 | 1.120 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.736905e-02 | 1.059 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.187679e-02 | 1.285 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.179904e-02 | 1.144 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.161924e-02 | 1.210 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.677621e-02 | 1.175 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.208821e-02 | 1.207 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.205696e-02 | 1.142 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.019265e-02 | 1.220 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.704001e-02 | 1.113 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.385555e-02 | 1.028 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.530298e-02 | 1.123 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.059901e-02 | 1.043 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 8.192037e-02 | 1.087 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 8.192037e-02 | 1.087 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.192037e-02 | 1.087 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.167954e-02 | 1.038 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.004764e-01 | 0.998 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.726152e-02 | 1.059 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.726628e-02 | 1.172 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.530298e-02 | 1.123 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.280904e-02 | 1.138 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.059497e-02 | 1.043 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.727074e-02 | 1.242 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.267405e-02 | 1.083 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 5.779550e-02 | 1.238 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.179904e-02 | 1.144 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.960038e-02 | 1.048 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.000819e-01 | 1.000 | 1 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.033007e-02 | 1.219 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.038345e-01 | 0.984 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.038345e-01 | 0.984 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.072231e-01 | 0.970 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.072231e-01 | 0.970 | 1 | 1 |
| G1 Phase | R-HSA-69236 | 1.072231e-01 | 0.970 | 1 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.072231e-01 | 0.970 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.077441e-01 | 0.968 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.077737e-01 | 0.967 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.106410e-01 | 0.956 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.106410e-01 | 0.956 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.106410e-01 | 0.956 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.106410e-01 | 0.956 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.108895e-01 | 0.955 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.108895e-01 | 0.955 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.108895e-01 | 0.955 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.108895e-01 | 0.955 | 1 | 1 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.108895e-01 | 0.955 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.108895e-01 | 0.955 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 1.108895e-01 | 0.955 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.108895e-01 | 0.955 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.108895e-01 | 0.955 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.122527e-01 | 0.950 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.122527e-01 | 0.950 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.122527e-01 | 0.950 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.140874e-01 | 0.943 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.145187e-01 | 0.941 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.168020e-01 | 0.933 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.175612e-01 | 0.930 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.203425e-01 | 0.920 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.203425e-01 | 0.920 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.203425e-01 | 0.920 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.203425e-01 | 0.920 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.203425e-01 | 0.920 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.203425e-01 | 0.920 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.203425e-01 | 0.920 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.203425e-01 | 0.920 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 1.203425e-01 | 0.920 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.203425e-01 | 0.920 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.203425e-01 | 0.920 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.203425e-01 | 0.920 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.203425e-01 | 0.920 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.208366e-01 | 0.918 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.210614e-01 | 0.917 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.210614e-01 | 0.917 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.210614e-01 | 0.917 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.214195e-01 | 0.916 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.245872e-01 | 0.905 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.245872e-01 | 0.905 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.270052e-01 | 0.896 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.281376e-01 | 0.892 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.281376e-01 | 0.892 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.296956e-01 | 0.887 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.296956e-01 | 0.887 | 1 | 1 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.296956e-01 | 0.887 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.296956e-01 | 0.887 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.296956e-01 | 0.887 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.296956e-01 | 0.887 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.296956e-01 | 0.887 | 1 | 1 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.296956e-01 | 0.887 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.296956e-01 | 0.887 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.296956e-01 | 0.887 | 1 | 1 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.296956e-01 | 0.887 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.296956e-01 | 0.887 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.296956e-01 | 0.887 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.317116e-01 | 0.880 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.317116e-01 | 0.880 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.353084e-01 | 0.869 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.353084e-01 | 0.869 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.353084e-01 | 0.869 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.353084e-01 | 0.869 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.380903e-01 | 0.860 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.389272e-01 | 0.857 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.389272e-01 | 0.857 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.389272e-01 | 0.857 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.389497e-01 | 0.857 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.389497e-01 | 0.857 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.389497e-01 | 0.857 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.389497e-01 | 0.857 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.389497e-01 | 0.857 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.389497e-01 | 0.857 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.389497e-01 | 0.857 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.405332e-01 | 0.852 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.415091e-01 | 0.849 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.425669e-01 | 0.846 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.462269e-01 | 0.835 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.472352e-01 | 0.832 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.481061e-01 | 0.829 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.481061e-01 | 0.829 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.481061e-01 | 0.829 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.499062e-01 | 0.824 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.499062e-01 | 0.824 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.504482e-01 | 0.823 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.509438e-01 | 0.821 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.510991e-01 | 0.821 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.510991e-01 | 0.821 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.536040e-01 | 0.814 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.536040e-01 | 0.814 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.571656e-01 | 0.804 | 1 | 1 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.571656e-01 | 0.804 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.571656e-01 | 0.804 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.571656e-01 | 0.804 | 1 | 1 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.571656e-01 | 0.804 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.571656e-01 | 0.804 | 1 | 1 |
| MET activates RAS signaling | R-HSA-8851805 | 1.571656e-01 | 0.804 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.571656e-01 | 0.804 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.571656e-01 | 0.804 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.571656e-01 | 0.804 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.571656e-01 | 0.804 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.571656e-01 | 0.804 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.571656e-01 | 0.804 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.571656e-01 | 0.804 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.571656e-01 | 0.804 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.571656e-01 | 0.804 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.571656e-01 | 0.804 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.571656e-01 | 0.804 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.571656e-01 | 0.804 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.580280e-01 | 0.801 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.640954e-01 | 0.785 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.648009e-01 | 0.783 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.648009e-01 | 0.783 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.648009e-01 | 0.783 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.661294e-01 | 0.780 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.661294e-01 | 0.780 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.661294e-01 | 0.780 | 1 | 1 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.661294e-01 | 0.780 | 1 | 1 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.661294e-01 | 0.780 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.661294e-01 | 0.780 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.661294e-01 | 0.780 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.685650e-01 | 0.773 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.685650e-01 | 0.773 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.709147e-01 | 0.767 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.709147e-01 | 0.767 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.723438e-01 | 0.764 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.735279e-01 | 0.761 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.749983e-01 | 0.757 | 1 | 1 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.749983e-01 | 0.757 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.749983e-01 | 0.757 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.749983e-01 | 0.757 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.749983e-01 | 0.757 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.749983e-01 | 0.757 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.749983e-01 | 0.757 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.749983e-01 | 0.757 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.749983e-01 | 0.757 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.787881e-01 | 0.748 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.787881e-01 | 0.748 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.799425e-01 | 0.745 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.837735e-01 | 0.736 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.837735e-01 | 0.736 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.837735e-01 | 0.736 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.837735e-01 | 0.736 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.837735e-01 | 0.736 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.837735e-01 | 0.736 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.837735e-01 | 0.736 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.837735e-01 | 0.736 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.837735e-01 | 0.736 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.837735e-01 | 0.736 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.914328e-01 | 0.718 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.924559e-01 | 0.716 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.924559e-01 | 0.716 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.924559e-01 | 0.716 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.924559e-01 | 0.716 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.924559e-01 | 0.716 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.924559e-01 | 0.716 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.948223e-01 | 0.710 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.952848e-01 | 0.709 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.991466e-01 | 0.701 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.010464e-01 | 0.697 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.010464e-01 | 0.697 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.010464e-01 | 0.697 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.010464e-01 | 0.697 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.010464e-01 | 0.697 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.030176e-01 | 0.692 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.030176e-01 | 0.692 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.030176e-01 | 0.692 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.030176e-01 | 0.692 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.068972e-01 | 0.684 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.068972e-01 | 0.684 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.068972e-01 | 0.684 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.068972e-01 | 0.684 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.068972e-01 | 0.684 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.077300e-01 | 0.683 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.077300e-01 | 0.683 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.095461e-01 | 0.679 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.095461e-01 | 0.679 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.095461e-01 | 0.679 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.095461e-01 | 0.679 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.107848e-01 | 0.676 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.107848e-01 | 0.676 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.139554e-01 | 0.670 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.146797e-01 | 0.668 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.146797e-01 | 0.668 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.179559e-01 | 0.662 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.179559e-01 | 0.662 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.179559e-01 | 0.662 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.179559e-01 | 0.662 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.179559e-01 | 0.662 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.179559e-01 | 0.662 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.179559e-01 | 0.662 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.250656e-01 | 0.648 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.262767e-01 | 0.645 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.262767e-01 | 0.645 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.262767e-01 | 0.645 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.262767e-01 | 0.645 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.262767e-01 | 0.645 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.262767e-01 | 0.645 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.262767e-01 | 0.645 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.262767e-01 | 0.645 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.262767e-01 | 0.645 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.342443e-01 | 0.630 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.342443e-01 | 0.630 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.342443e-01 | 0.630 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.345095e-01 | 0.630 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.345095e-01 | 0.630 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.345095e-01 | 0.630 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.345095e-01 | 0.630 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.345095e-01 | 0.630 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.426552e-01 | 0.615 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.426552e-01 | 0.615 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.426552e-01 | 0.615 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.426552e-01 | 0.615 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.426552e-01 | 0.615 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.426552e-01 | 0.615 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.426552e-01 | 0.615 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.426552e-01 | 0.615 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.507147e-01 | 0.601 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.507147e-01 | 0.601 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.507147e-01 | 0.601 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.507147e-01 | 0.601 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.507147e-01 | 0.601 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.507147e-01 | 0.601 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.507147e-01 | 0.601 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.507147e-01 | 0.601 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.507147e-01 | 0.601 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.539090e-01 | 0.595 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.578483e-01 | 0.589 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.578483e-01 | 0.589 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.586890e-01 | 0.587 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.586890e-01 | 0.587 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.586890e-01 | 0.587 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.586890e-01 | 0.587 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.617886e-01 | 0.582 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.647312e-01 | 0.577 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.657294e-01 | 0.576 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.657294e-01 | 0.576 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.665789e-01 | 0.574 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.665789e-01 | 0.574 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.665789e-01 | 0.574 | 1 | 1 |
| Syndecan interactions | R-HSA-3000170 | 2.665789e-01 | 0.574 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.665789e-01 | 0.574 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.717287e-01 | 0.566 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.733507e-01 | 0.563 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.743852e-01 | 0.562 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.743852e-01 | 0.562 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.743852e-01 | 0.562 | 1 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.743852e-01 | 0.562 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.743852e-01 | 0.562 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.743852e-01 | 0.562 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.762308e-01 | 0.559 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.814890e-01 | 0.551 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.821090e-01 | 0.550 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.821090e-01 | 0.550 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.821090e-01 | 0.550 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.821090e-01 | 0.550 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.821090e-01 | 0.550 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.821090e-01 | 0.550 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.821090e-01 | 0.550 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.821090e-01 | 0.550 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.821090e-01 | 0.550 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.897510e-01 | 0.538 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.897510e-01 | 0.538 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.897510e-01 | 0.538 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.897510e-01 | 0.538 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.897510e-01 | 0.538 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.897510e-01 | 0.538 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.935705e-01 | 0.532 | 1 | 1 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.954085e-01 | 0.530 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.973122e-01 | 0.527 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.973122e-01 | 0.527 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.973122e-01 | 0.527 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.973122e-01 | 0.527 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.973122e-01 | 0.527 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.973122e-01 | 0.527 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.973122e-01 | 0.527 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.973122e-01 | 0.527 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.011488e-01 | 0.521 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.011488e-01 | 0.521 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.047933e-01 | 0.516 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.047933e-01 | 0.516 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.047933e-01 | 0.516 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.047933e-01 | 0.516 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.047933e-01 | 0.516 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.121952e-01 | 0.506 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.121952e-01 | 0.506 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 3.121952e-01 | 0.506 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.121952e-01 | 0.506 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.121952e-01 | 0.506 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.121952e-01 | 0.506 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.121952e-01 | 0.506 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.129047e-01 | 0.505 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.195188e-01 | 0.496 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.195188e-01 | 0.496 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.195188e-01 | 0.496 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.207192e-01 | 0.494 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.267648e-01 | 0.486 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.267648e-01 | 0.486 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.267648e-01 | 0.486 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.267648e-01 | 0.486 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.313346e-01 | 0.480 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.324001e-01 | 0.478 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.324001e-01 | 0.478 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.339342e-01 | 0.476 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.339342e-01 | 0.476 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.342424e-01 | 0.476 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.362815e-01 | 0.473 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 3.364247e-01 | 0.473 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.401564e-01 | 0.468 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.410276e-01 | 0.467 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.410276e-01 | 0.467 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.410276e-01 | 0.467 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.410276e-01 | 0.467 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.410276e-01 | 0.467 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.410276e-01 | 0.467 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.478851e-01 | 0.459 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.478851e-01 | 0.459 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.480459e-01 | 0.458 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.517384e-01 | 0.454 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.549899e-01 | 0.450 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.549899e-01 | 0.450 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.549899e-01 | 0.450 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.549899e-01 | 0.450 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.549899e-01 | 0.450 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.555839e-01 | 0.449 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.574754e-01 | 0.447 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 3.603279e-01 | 0.443 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.618603e-01 | 0.441 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.618603e-01 | 0.441 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.618603e-01 | 0.441 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.632507e-01 | 0.440 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.632507e-01 | 0.440 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.670714e-01 | 0.435 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.670714e-01 | 0.435 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.686580e-01 | 0.433 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.686580e-01 | 0.433 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.686580e-01 | 0.433 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.686580e-01 | 0.433 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.686580e-01 | 0.433 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.686580e-01 | 0.433 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.708833e-01 | 0.431 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.753837e-01 | 0.426 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.753837e-01 | 0.426 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 3.753837e-01 | 0.426 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 3.753837e-01 | 0.426 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.820382e-01 | 0.418 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 3.820382e-01 | 0.418 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.820382e-01 | 0.418 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.886222e-01 | 0.410 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.886222e-01 | 0.410 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.886222e-01 | 0.410 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.886222e-01 | 0.410 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.886222e-01 | 0.410 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.951364e-01 | 0.403 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.951364e-01 | 0.403 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.951364e-01 | 0.403 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.951364e-01 | 0.403 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.951364e-01 | 0.403 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 4.010342e-01 | 0.397 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.015816e-01 | 0.396 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.015816e-01 | 0.396 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.079586e-01 | 0.389 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.079586e-01 | 0.389 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.084683e-01 | 0.389 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.232013e-01 | 0.373 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 4.234332e-01 | 0.373 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.266868e-01 | 0.370 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.266868e-01 | 0.370 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.266868e-01 | 0.370 | 1 | 1 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.327978e-01 | 0.364 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.327978e-01 | 0.364 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.327978e-01 | 0.364 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.327978e-01 | 0.364 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.388439e-01 | 0.358 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.388439e-01 | 0.358 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.388439e-01 | 0.358 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.388439e-01 | 0.358 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.388439e-01 | 0.358 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.388439e-01 | 0.358 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.413497e-01 | 0.355 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.448260e-01 | 0.352 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.507447e-01 | 0.346 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.507447e-01 | 0.346 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.566006e-01 | 0.340 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.566006e-01 | 0.340 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.566006e-01 | 0.340 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.623945e-01 | 0.335 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.623945e-01 | 0.335 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.681270e-01 | 0.330 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.737986e-01 | 0.324 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.794102e-01 | 0.319 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.794102e-01 | 0.319 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.794102e-01 | 0.319 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.904554e-01 | 0.309 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.958903e-01 | 0.305 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 4.958903e-01 | 0.305 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.958903e-01 | 0.305 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.958903e-01 | 0.305 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.012676e-01 | 0.300 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.065879e-01 | 0.295 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.106392e-01 | 0.292 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.118517e-01 | 0.291 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.118517e-01 | 0.291 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.118517e-01 | 0.291 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.118517e-01 | 0.291 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.118517e-01 | 0.291 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.170597e-01 | 0.286 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.170597e-01 | 0.286 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.170597e-01 | 0.286 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.170597e-01 | 0.286 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.170597e-01 | 0.286 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.170597e-01 | 0.286 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.170794e-01 | 0.286 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.172566e-01 | 0.286 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 5.222124e-01 | 0.282 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 5.265009e-01 | 0.279 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.273105e-01 | 0.278 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.273105e-01 | 0.278 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.303134e-01 | 0.275 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.367519e-01 | 0.270 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.367519e-01 | 0.270 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.373450e-01 | 0.270 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.399485e-01 | 0.268 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.431300e-01 | 0.265 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.444960e-01 | 0.264 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.462963e-01 | 0.263 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.495394e-01 | 0.260 | 1 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.520010e-01 | 0.258 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.520010e-01 | 0.258 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.520010e-01 | 0.258 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.567830e-01 | 0.254 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.582327e-01 | 0.253 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.588087e-01 | 0.253 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.644730e-01 | 0.248 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.661954e-01 | 0.247 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.708267e-01 | 0.243 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.754089e-01 | 0.240 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.754089e-01 | 0.240 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.799425e-01 | 0.237 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 5.799425e-01 | 0.237 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.844280e-01 | 0.233 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.888658e-01 | 0.230 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.888658e-01 | 0.230 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.888658e-01 | 0.230 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.932565e-01 | 0.227 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.932565e-01 | 0.227 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.976005e-01 | 0.224 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.018985e-01 | 0.220 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.018985e-01 | 0.220 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.061508e-01 | 0.217 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.092315e-01 | 0.215 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.103580e-01 | 0.214 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.145204e-01 | 0.211 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.145204e-01 | 0.211 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.145204e-01 | 0.211 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.186387e-01 | 0.209 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.278401e-01 | 0.202 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.307328e-01 | 0.200 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.307328e-01 | 0.200 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.385830e-01 | 0.195 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.424456e-01 | 0.192 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.526003e-01 | 0.185 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.537889e-01 | 0.185 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.574900e-01 | 0.182 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.638143e-01 | 0.178 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.647744e-01 | 0.177 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.647744e-01 | 0.177 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.719048e-01 | 0.173 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.719048e-01 | 0.173 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 6.754133e-01 | 0.170 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.823187e-01 | 0.166 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.823187e-01 | 0.166 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.890780e-01 | 0.162 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.924039e-01 | 0.160 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 6.930765e-01 | 0.159 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.177683e-01 | 0.144 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.299147e-01 | 0.137 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.354168e-01 | 0.133 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.402720e-01 | 0.131 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.410523e-01 | 0.130 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.438251e-01 | 0.129 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.463233e-01 | 0.127 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.492825e-01 | 0.125 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.496612e-01 | 0.125 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.508409e-01 | 0.124 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.546243e-01 | 0.122 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.561417e-01 | 0.121 | 1 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.572527e-01 | 0.121 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.699803e-01 | 0.114 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.724450e-01 | 0.112 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.912407e-01 | 0.102 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.934789e-01 | 0.100 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.934789e-01 | 0.100 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.956933e-01 | 0.099 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.081935e-01 | 0.092 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.125788e-01 | 0.090 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.145971e-01 | 0.089 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.299216e-01 | 0.081 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.330416e-01 | 0.079 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.405873e-01 | 0.075 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.521928e-01 | 0.069 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.629580e-01 | 0.064 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.684131e-01 | 0.061 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.687557e-01 | 0.061 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.701666e-01 | 0.060 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.796296e-01 | 0.056 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.831066e-01 | 0.054 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.998974e-01 | 0.046 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.120564e-01 | 0.040 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.151763e-01 | 0.038 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.181026e-01 | 0.037 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.227809e-01 | 0.035 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.394248e-01 | 0.027 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.446229e-01 | 0.025 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.597574e-01 | 0.018 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.756241e-01 | 0.011 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.840648e-01 | 0.007 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.887887e-01 | 0.005 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.902786e-01 | 0.004 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.921952e-01 | 0.003 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.972906e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.986958e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.994728e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999921e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999999e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
